Myocardial infarction, without ST-elevation

I9_NSTEMI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I21.4 Cause of death: ICD-10 — I21.4 2 out of 7 registries used, show all original rules.	22755
4. Check minimum number of events None	22755
5. Include endpoints None	22755
6. Filter based on genotype QC (FinnGen only)	20194

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I21
Name in latin: Infarctus subendocardialis acutus

NAME	I9_NSTEMI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I214
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I214
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Myocardial infarction, without ST-elevation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	20194	6868	13326
Unadjusted period prevalence (%)	4.86	2.44	6.11
Median age at first event (years)	71.75	73.56	70.81

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20823: Matched controls
187805

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

10.5

318.2

372

326

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.7

316.9

1076

2717

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

307.7

6778

25279

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

9.7

307.7

1615

1606

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

9.5

307.7

491

475

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.4

307.7

3656

15585

K74

ICPC

Ischaemic heart dis with angina

5.9

307.7

672

1057

A10AC01

ATC

insulin (human); parenteral

2.8

307.7

2332

8230

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

7.2

307.7

1159

1518

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

4.4

307.7

4341

10562

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

307.7

2351

6823

AA1

Conventional CABG

4.8

307.7

934

1832

I25

ICD-10 Finland

Chronic ischaemic heart disease

5.4

307.7

2885

5476

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

307.7

3345

15151

I50.0

ICD-10 Finland

Congestive heart failure

3.2

307.7

3726

12023

I20.01

ICD-10 Finland

Unstable angina

7.8

307.7

2089

2657

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

7.8

307.7

1933

2428

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.9

307.7

1599

3965

I25.2

ICD-10 Finland

Old myocardial infarction

9.7

307.7

5974

7452

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

8.1

307.7

3461

4525

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

4.4

307.7

3941

9505

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.1

307.7

1623

4938

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.5

307.7

2465

9648

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

10.8

307.7

539

463

A02BC02

ATC

pantoprazole; systemic

2.1

307.7

15104

105716

ZXD00

NOMESCO Finland

Emergency procedure

4.6

307.7

1146

2339

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

10.1

307.7

775

719

AN2

Balloon angioplasty, including several vessels

6.2

307.7

1511

2350

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

12.5

307.7

1452

1121

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

11.9

307.7

14031

27788

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

11.8

307.7

581

457

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

307.7

6312

31357

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

4.7

307.7

1189

2391

I20.09

ICD-10 Finland

Unstable angina

7.7

307.7

4240

6022

C10AA05

ATC

atorvastatin; oral

3.4

307.7

13795

68293

C08CA01

ATC

amlodipine; oral

1.9

307.7

10329

64962

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

5.8

307.7

2986

5225

C07AB07

ATC

bisoprolol; oral

4.4

307.7

16158

82795

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

307.7

9039

38686

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

8.3

307.7

2823

3477

I25.1

ICD-10 Finland

Atherosclerotic heart disease

11.8

307.7

15449

36795

B01AC24

ATC

ticagrelor; oral

29.3

307.7

4614

1806

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

307.7

7113

39070

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

307.7

7085

23815

C10AX09

ATC

ezetimibe; oral

3.7

307.7

6641

21097

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.7

307.7

2523

5387

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

307.7

6457

35291

ZXD05

NOMESCO Finland

Urgent procedure

3.4

307.7

9430

36876

A10AE04

ATC

insulin glargine; parenteral

2.6

307.7

3056

11450

AN3

Balloon angioplasty and metallic stent

8.0

307.7

1882

2306

R06.0

ICD-10 Finland

Dyspnoea

1.9

307.7

6787

38530

I50.1

ICD-10 Finland

Left ventricular failure

3.6

307.7

2375

6511

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

5.1

307.7

6200

14538

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.0

307.7

3997

13765

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

307.7

13264

76552

WX892

NOMESCO Finland

Monitored bed care

2.6

307.7

2336

8677

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

8.8

307.7

4143

5172

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

5.9

307.7

1208

1944

A10AB05

ATC

insulin aspart; parenteral

2.8

307.7

2371

8281

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

307.7

3289

14752

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

12.3

307.7

1003

771

AN1

Coronary angiography

6.1

307.7

6953

14341

280

Kela drug reimbursment

Clopidogrel

9.2

307.7

1033

1055

C10AA01

ATC

simvastatin; oral

2.4

307.7

12721

74322

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

307.7

2162

8074

A11

ICPC

Chest pain NOS

2.6

307.7

2568

9647

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

15547.9

307.7

9925

WX872

NOMESCO Finland

Intensive care

4.0

307.7

2180

5281

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

4.3

307.7

1745

3893

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.9

307.7

6562

37034

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.0

307.7

6809

26328

C07AB02

ATC

metoprolol; systemic

2.1

307.7

6147

31647

C03DA01

ATC

spironolactone; oral

2.3

307.7

4030

17875

Angiography of the heart and coronary arteries

3.8

307.7

3074

8223

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

5.3

307.7

959

1689

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

5.6

307.7

924

1538

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.4

307.7

3295

13765

I20.00

ICD-10 Finland

Unstable angina

6.3

307.7

1879

2933

AN4

Balloon angioplasty and drug eluding stent

9.7

307.7

2510

2608

Single vessel balloon catheter extension

5.9

307.7

1247

2015

C01DA14

ATC

isosorbide mononitrate; oral

5.3

307.7

9535

25942

B01AC04

ATC

clopidogrel; oral

7.3

307.7

10532

23109

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.0

307.7

8183

33617

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4581.5

307.7

13402

K76

ICPC

Ischaemic heart dis without angina

4.8

307.7

1318

2588

C03CA01

ATC

furosemide; systemic

2.8

307.7

11439

57493

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.2

307.7

8631

34118

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

8.1

307.7

541

619

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.8

307.7

3169

8526

A10BA02

ATC

metformin; oral

1.8

307.7

7554

44472

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

13.0

307.7

5854

5470

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

7.8

307.7

14066

39748

I10

ICD-10 Finland

Essential (primary) hypertension

2.1

307.7

15652

110541

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2820.5

307.7

4623

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

388.6

307.7

1953

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

5.0

307.7

3623

7628

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

307.7

4739

21372

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.6

307.7

2628

4724

C09AA05

ATC

ramipril; oral

3.2

307.7

9656

39643

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

12.4

307.7

14986

32232

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

307.7

7710

42342

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.6

307.3

1977

7247

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

22.3

307.2

242

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

5.0

305.3

688

1263

XF402

NOMESCO Finland

ECG with work load test

2.2

297.9

2950

13100

Coronary artery bypass surgery

3.7

296.1

992

2480

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

294.0

7258

43814

K84

ICPC

Heart disease other

3.4

284.5

1099

3020

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.0

281.6

640

1183

T90

ICPC

Diabetes non-insulin dependent

1.8

272.6

6263

36861

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

268.0

4024

20748

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

263.0

6792

41220

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.4

262.6

699

1473

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.6

261.9

666

1353

B01AC06

ATC

acetylsalicylic acid; oral

2.9

260.3

1340

4362

FL1AC

NOMESCO Finland

Left cardioangiography

4.2

257.0

715

1559

C10AA07

ATC

rosuvastatin; oral

1.7

255.9

7319

45583

205

Kela drug reimbursment

Chronic hypertension

1.7

253.4

7586

47790

A10AE05

ATC

insulin detemir; parenteral

2.7

250.5

1441

4974

I20.0

ICD-10 Finland

Unstable angina

6.3

249.8

445

653

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

244.9

5197

29726

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.7

237.4

576

1125

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

236.5

2534

11535

R07.3

ICD-10 Finland

Other chest pain

2.1

235.2

2500

11345

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

4.0

223.4

669

1541

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.6

223.2

800

2089

R4110

NOMESCO Finland

Physiotherapy

1.7

221.9

5976

36328

A10BK03

ATC

empagliflozin; oral

2.0

219.3

2664

12684

I20.91

ICD-10 Finland

Angina pectoris, unspecified

4.4

218.1

572

1190

207

Kela drug reimbursment

Chronic arrhythmias

1.7

217.8

4786

27506

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.2

217.5

604

1314

A10BB12

ATC

glimepiride; oral

2.2

217.4

2179

9647

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.2

217.3

2003

8575

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

211.9

1678

6732

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

9.1

209.4

269

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

9.3

203.9

259

255

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.1

202.1

586

1317

FN2EA

NOMESCO Finland

Coronary rotablation

9.4

200.1

251

243

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.0

200.0

607

1411

C10AA03

ATC

pravastatin; oral

2.1

199.4

2043

9109

AA1AD

NOMESCO Finland

CT of head and brain

1.6

197.3

7128

46306

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

7.9

194.7

281

326

A10AB01

ATC

insulin (human); parenteral

3.2

194.1

809

2324

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

6.6

193.6

325

448

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

193.1

1244

4531

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

891.4

192.3

196

FN2CD

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of vein graft

24.6

192.2

146

ZXE00

NOMESCO Finland

One hour or less

1.6

190.9

7566

50118

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.5

189.8

284

344

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

188.8

1905

8435

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

8.8

188.2

249

259

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

4.0

187.4

568

1319

Z50.0

ICD-10 Finland

Cardiac rehabilitation

4.6

185.9

467

938

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

185.3

1422

5616

C10AA04

ATC

fluvastatin; oral

2.0

184.3

2445

11958

AP1

Catheterization of the left side of the heart

3.8

182.2

590

1436

PD5AD

NOMESCO Finland

CT of aorta

3.1

181.7

824

2488

I20

ICD-10 Finland

Angina pectoris

3.9

180.8

566

1345

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.8

179.7

582

1417

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

179.4

4817

28976

A10BH05

ATC

linagliptin; oral

2.2

178.5

1581

6637

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.5

178.5

640

1670

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.1

176.7

1977

9093

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

175.9

2042

9520

PE1AT

NOMESCO Finland

Femoral artery PTA

4.1

175.0

500

1111

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

174.5

731

2105

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

174.3

3069

16417

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.5

172.6

1213

4599

A10AA02, ,

ATC

2.9

172.4

852

2701

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

172.0

1047

3705

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

170.0

3129

16949

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.6

166.6

591

1531

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

5.2

166.5

360

636

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

166.3

726

2143

B01AA03

ATC

warfarin; systemic

1.6

164.7

5480

34607

A10AA01, ,

ATC

3.6

164.5

568

1445

I21

ICD-10 Finland

Acute myocardial infarction

11.7

164.0

177

137

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

162.7

6266

40881

SPAT1262

SPAT

Handing over of treatment supplies

1.7

162.6

4091

24119

NHQ40

NOMESCO Finland

Amputation of toe

3.4

162.3

613

1654

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

160.1

1309

5306

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.7

159.3

542

1365

N02BE01

ATC

paracetamol; systemic, rectal

1.7

158.7

17895

146281

M04AA01

ATC

allopurinol; systemic

1.7

158.1

3736

21650

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

157.4

1104

4178

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

156.7

4321

26035

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

155.8

1564

6891

A10AB04

ATC

insulin lispro; parenteral

3.2

155.0

651

1877

R02

ICPC

Shortness of breath/dyspnoea

1.7

153.7

3090

17123

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

4.6

153.1

385

774

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.3

152.7

411

872

B01AF02

ATC

apixaban; oral

1.7

151.9

3699

21576

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.4

150.7

560

1495

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.1

150.5

676

2028

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

150.2

6321

41877

TK800

NOMESCO Finland

Hemodialysis

3.2

149.0

623

1791

C10AX13

ATC

evolocumab; parenteral

7.2

147.3

229

290

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

146.9

2990

16608

FXZ00

NOMESCO Finland

Off-pump cardiac operation

5.6

146.4

288

466

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

146.2

1367

5853

A10BH01

ATC

sitagliptin; oral

1.8

146.0

2378

12373

H3603, E103,

ICD-10 Finland

6.3

145.4

254

365

K75

ICPC

Acute myocardial infarction

9.0

145.4

189

192

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

145.0

790

2638

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.1

144.2

654

1973

A10BK01

ATC

dapagliflozin; oral

1.9

143.0

1928

9437

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

138.2

3706

22092

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

2.9

137.7

686

2182

T89

ICPC

Diabetes insulin dependent

2.7

137.2

772

2621

XF404

NOMESCO Finland

Ambulatory ECG

1.9

136.9

2056

10417

N02AX02

ATC

tramadol; systemic, rectal

1.4

135.7

8887

63894

R53

ICD-10 Finland

Malaise and fatigue

1.5

134.8

5083

32744

Multi-vessel balloon catheter extension

5.6

134.5

268

439

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

3.2

134.3

572

1662

SPAT1254

SPAT

Administration of medicine

1.6

134.2

3401

19972

Z3231

NOMESCO Finland

Registered nurse

1.5

134.0

5569

36613

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.4

133.9

1011

3951

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.6

133.6

454

1142

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

5.7

133.0

259

415

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

132.4

741

2508

A11CC03

ATC

alfacalcidol; systemic

2.9

132.1

666

2132

C09AA02

ATC

enalapril; systemic

1.5

131.9

4840

30972

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.9

131.2

246

380

Z2221

NOMESCO Finland

Medical doctor

1.5

130.9

5026

32468

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.8

130.4

683

2232

Z3226

NOMESCO Finland

Physiotherapist

1.6

129.6

3572

21397

250, ,

Kela drug reimbursment

2.8

129.4

666

2156

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

5.6

129.2

254

411

I50

ICD-10 Finland

Heart failure

2.3

128.8

1053

4259

S97

ICPC

Chronic ulcer skin

1.9

128.2

1717

8372

B01AC22

ATC

prasugrel; oral

7.5

127.4

191

232

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.7

127.1

246

392

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

6.2

125.6

223

326

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.9

124.5

635

2045

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.3

124.5

504

1420

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

4.6

124.2

306

605

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

124.0

1900

9673

I47.2

ICD-10 Finland

Ventricular tachycardia

2.9

123.5

618

1970

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.7

123.5

410

1015

AA2

Off pump CABG sternotomy

6.1

121.6

221

331

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

121.2

3154

18597

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

121.1

8445

60990

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

120.5

3194

18915

SPAT1097

SPAT

Recording of ECG

1.6

119.8

3273

19523

A10BB01

ATC

glibenclamide; oral

2.1

119.3

1281

5773

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.4

119.2

440

1169

A28

ICPC

Limited function/disability NOS

1.5

119.0

4727

30653

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

118.2

1090

4631

K77

ICPC

Heart failure

2.5

118.2

779

2858

R07.2

ICD-10 Finland

Precordial pain

3.0

118.0

564

1752

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.6

117.5

404

1024

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

117.4

7260

51237

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

3.9

116.4

361

852

K01

ICPC

Heart pain

3.4

116.1

438

1180

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

116.0

3248

19474

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.7

115.7

276

531

N19

ICD-10 Finland

Unspecified kidney failure

2.1

115.1

1111

4806

111

Conventional CABG

4.3

113.5

307

654

J01DB01

ATC

cefalexin; oral

1.5

113.4

15696

127085

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

112.6

1443

6921

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

112.4

3491

21426

C08DB01

ATC

diltiazem; oral

1.9

111.9

1497

7285

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

111.4

6872

48354

287

Kela drug reimbursment

Ticagrelor 60 mg

43.4

111.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

111.0

2855

16753

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.8

110.8

587

1929

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

110.7

4858

32067

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.4

110.5

412

1102

SPAT1263

SPAT

Sampling

1.4

109.5

7757

55868

H3603, E113,

ICD-10 Finland

4.4

109.5

289

604

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.4

106.9

763

2904

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.5

106.7

269

542

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

106.5

702

2575

C08CA13

ATC

lercanidipine; oral

1.6

106.3

3368

20737

C02AC05

ATC

moxonidine; oral

2.0

105.4

1177

5375

I21.42

ICD-10 Finland

Acute subendocardial infarction thrombus in coronary artery

969.2

105.2

107

B01AC07

ATC

dipyridamole; systemic

1.9

105.2

1371

6609

A12AA04

ATC

calcium carbonate; oral

3.1

104.9

447

1299

C01BD01

ATC

amiodarone; systemic

2.3

104.7

825

3281

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

104.1

2780

16441

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

103.4

2146

11901

315

Kela drug reimbursment

Clopidogrel

3.6

103.1

362

931

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.5

103.0

207

342

H3601, E113,

ICD-10 Finland

3.2

102.4

436

1266

H02AB06

ATC

prednisolone; systemic

1.4

102.4

9377

70197

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

4.9

100.7

233

437

A46

ICD-10 Finland

Erysipelas

1.5

100.5

3463

21688

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.7

100.3

330

812

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

100.2

584

2016

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

99.2

5707

39480

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.6

99.1

340

861

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.0

97.9

287

650

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.6

97.7

335

848

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

97.4

2693

16040

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

97.0

2135

12014

N03AX16

ATC

[U] pregabalin

1.5

96.7

4315

28458

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

6.1

96.4

173

256

Catheterization and pressure measurement of the left side of the heart

2.7

95.9

527

1765

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.9

95.5

476

1513

I20.10

ICD-10 Finland

Angina angiospastic

5.7

94.8

183

291

C08CA07

ATC

nisoldipine; oral

3.1

94.1

412

1217

A10AD05

ATC

insulin aspart; parenteral

2.7

93.7

546

1885

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.3

93.6

249

524

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

93.2

2068

11656

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

92.2

1638

8686

R55

ICD-10 Finland

Syncope and collapse

1.6

91.3

2630

15796

J01FF01

ATC

clindamycin; systemic

1.4

91.1

4919

33549

C08CA02

ATC

felodipine; oral

1.6

90.8

2373

13929

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.3

90.7

352

966

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

90.5

913

4011

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.6

90.4

312

793

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

8.8

90.4

119

123

M10.9

ICD-10 Finland

Gout, unspecified

1.7

90.1

1847

10188

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

89.9

875

3792

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

89.0

1274

6324

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.0

88.6

413

1265

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

88.5

7080

51502

PEN23

NOMESCO Finland

Plastic repair of femoral artery

3.5

88.1

316

824

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.8

88.1

458

1490

C09DX04

ATC

valsartan and sacubitril; oral

3.5

87.7

311

805

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

3.6

87.4

300

760

L28

ICPC

Limited function/disability (L)

1.4

86.6

4358

29307

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

3.6

86.1

297

755

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

85.6

3498

22605

H36.01

ICD-10 Finland

Diabetic maculopathy

3.3

85.0

333

919

J01MA12

ATC

levofloxacin; systemic

1.4

84.8

3972

26344

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

84.7

2094

12113

ANE

Coronary internal ultrasound (IVUS)

6.6

84.3

140

191

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

84.2

1680

9193

WX722

NOMESCO Finland

PEEP

2.0

84.2

1031

4858

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.9

83.5

1117

5422

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

82.9

551

2028

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.7

82.8

196

375

A04

ICPC

Weakness/tiredness general

1.5

82.8

3078

19505

A10AE06

ATC

insulin degludec; parenteral

2.3

82.4

646

2561

I20.8

ICD-10 Finland

Other forms of angina pectoris

3.7

81.9

272

674

R42

ICD-10 Finland

Dizziness and giddiness

1.4

81.6

4833

33386

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.9

81.4

1136

5589

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.7

81.3

264

644

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

80.3

1095

5347

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.1

79.5

789

3443

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.0

79.0

928

4308

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

78.9

1012

4842

V03AE01

ATC

polystyrene sulfonate; oral

2.9

78.1

381

1197

N18.0

ICD-10 Finland

End-stage renal disease

3.2

78.1

317

895

5315

FHL

Bypass surgery using a mammary artery

3.1

77.6

342

1014

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

4.2

77.5

211

452

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.4

77.5

544

2054

WX213

NOMESCO Finland

Lower leg blockade

3.7

77.0

252

618

C08CA05

ATC

nifedipine; systemic

1.7

76.9

1458

7861

SPAT1301

SPAT

No procedures

1.4

76.3

6066

43836

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.6

76.2

264

673

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

76.1

1020

4951

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

75.7

1474

8003

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

75.5

7822

58726

I51.4

ICD-10 Finland

Myocarditis, unspecified

5.8

75.3

143

224

J81

ICD-10 Finland

Pulmonary oedema

4.2

75.2

205

440

V03AE03

ATC

lanthanum carbonate; oral

6.2

74.8

133

195

I22.99

ICD-10 Finland

Recurrent infarction with unspecified location unspecified coronary artery status

7.8

74.6

108

126

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.2

74.5

302

852

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

74.3

3342

21936

J01MA02

ATC

ciprofloxacin; systemic

1.3

74.0

8022

60561

ZX120

NOMESCO Finland

Intravenous

1.6

73.4

1775

10194

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.2

73.3

203

441

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

73.0

1573

8773

K92

ICPC

Atherosclerosis/periph vascular dis

2.7

72.9

396

1319

137

Kela drug reimbursment

Uraemia requiring dialysis

3.8

72.7

231

555

J01CA04

ATC

amoxicillin; systemic

1.3

72.4

14466

118538

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.8

72.1

226

538

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.3

72.0

151

260

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.1

71.7

304

881

A10AD01

ATC

insulin (human); parenteral

2.6

71.7

429

1501

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

71.5

3175

20772

R2110

NOMESCO Finland

Giving the first information

1.9

71.1

975

4766

5314

FHL

Bypass surgery for four or more vessels

3.4

70.8

269

729

H3600, E103,

ICD-10 Finland

4.4

70.6

184

381

H3600, E113,

ICD-10 Finland

2.9

70.5

347

1096

R03BB04

ATC

tiotropium bromide; inhalant

1.5

70.4

2316

14266

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

70.1

2069

12447

H3601, E103,

ICD-10 Finland

4.5

69.9

175

351

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.6

69.9

237

596

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

4.2

69.8

191

411

C09CA01

ATC

losartan; oral

1.3

69.5

5382

38619

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

69.3

2334

14446

C07AG02

ATC

carvedilol; oral

1.7

69.0

1395

7648

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

68.9

1221

6453

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

68.8

877

4185

V03AE02

ATC

sevelamer; oral

4.7

68.5

162

310

A12BA01

ATC

potassium chloride; oral

1.8

68.2

1153

6012

R11

ICD-10 Finland

Nausea and vomiting

1.6

68.1

1573

8923

SPAT1104

SPAT

Monitoring of emergency patient

1.7

67.6

1311

7106

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.0

67.4

149

269

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.4

67.2

486

1860

I49.5

ICD-10 Finland

Sick sinus syndrome

1.8

66.5

1015

5132

C02DE04, ,

ATC

2.0

66.0

723

3271

R04.0

ICD-10 Finland

Epistaxis

1.6

65.9

1744

10224

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

2.8

65.3

335

1082

PD4AD

NOMESCO Finland

CT of lower extremity arteries

3.2

65.3

272

780

R03AC02

ATC

salbutamol; inhalant

1.3

65.0

9131

70930

5253

FHL

Cardiac lung machine

3.1

64.6

279

818

C03AA03

ATC

hydrochlorothiazide; oral

1.5

64.6

2038

12429

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

2.2

64.5

567

2358

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

64.4

1172

6238

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

64.2

604

2581

Z49.2

ICD-10 Finland

Other dialysis

4.0

64.0

188

427

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.7

63.9

212

525

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

63.8

8478

65335

1CX08, ,

NOMESCO Finland

4.9

63.6

145

269

I42.8

ICD-10 Finland

Other cardiomyopathies

4.6

63.4

155

305

WX720

NOMESCO Finland

Own respiration

1.8

63.3

923

4600

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

4.5

63.1

158

317

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.2

62.9

259

738

K92.1

ICD-10 Finland

Melaena

1.7

62.8

1293

7116

K29

ICPC

Cardiovascular sympt/complt other

1.8

62.8

1032

5334

C10AA02

ATC

lovastatin; oral

1.8

62.7

1008

5176

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

62.6

7212

54526

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

62.2

768

3625

B05DA

ATC

Isotonic solutions

3.9

61.5

187

436

K22

ICPC

Risk factor cardiovascular disease

1.7

61.3

1242

6807

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

60.8

442

1695

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

60.6

1898

11546

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

60.5

5912

43680

WX890

NOMESCO Finland

Intesive care monitoring

3.5

60.2

212

547

K02

ICPC

Pressure/tightness of heart

2.2

60.0

505

2063

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

60.0

602

2637

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

59.8

2552

16521

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

59.8

3293

22308

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

4.0

59.5

174

394

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

59.0

6532

49022

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

3.6

58.7

197

492

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

3.8

58.4

187

452

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.7

58.4

1089

5832

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.0

58.4

668

3070

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

3.7

58.3

187

453

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

57.5

713

3370

C09AA04

ATC

perindopril; oral

1.7

57.4

1137

6190

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.3

57.4

452

1796

C09CA03

ATC

valsartan; oral

1.5

57.2

1949

12063

WX882

NOMESCO Finland

High dependency care

2.1

56.8

582

2569

B05DB

ATC

Hypertonic solutions

3.9

56.8

172

400

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

56.7

1633

9748

PEC23

NOMESCO Finland

Suture of common femoral artery

4.7

56.5

135

261

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

56.4

2486

16182

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.2

56.3

510

2147

M79.6

ICD-10 Finland

Pain in limb

1.3

56.3

7345

56195

UJF32

NOMESCO Finland

Coloscopy

1.3

56.0

5170

37818

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

55.8

1494

8769

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

55.7

1874

11565

J01DA01

ATC

[U] cefalexin

1.3

55.7

10973

88116

I25.40

ICD-10 Finland

Coronary artery aneurysm

15.2

55.7

A10BH02

ATC

vildagliptin; oral

2.2

55.4

476

1961

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

55.4

3218

21964

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.1

54.6

512

2185

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

54.5

279

901

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

54.5

1393

8088

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

54.4

834

4219

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

53.8

890

4605

FN2EX

NOMESCO Finland

Other catheter-based coronary intervention

10.8

53.8

A02BC01

ATC

omeprazole; systemic

1.3

53.6

5176

38048

R50.9

ICD-10 Finland

Fever, unspecified

1.4

52.5

2741

18366

A10BJ06

ATC

semaglutide; parenteral

1.8

51.6

849

4386

L17

ICPC

Foot/toe symptom/complaint

1.3

51.6

5392

40010

SPAT1216

SPAT

Assessment of functional ability

1.4

51.5

3364

23361

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

2.7

51.5

293

1000

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

51.5

2001

12702

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.8

51.5

743

3689

4140B

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]

2.9

51.4

251

790

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

51.4

2438

16061

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.0

51.3

595

2747

I24.1

ICD-10 Finland

Dressler syndrome

8.8

51.1

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.7

51.1

279

933

M48.0

ICD-10 Finland

Spinal stenosis

1.4

51.0

2658

17795

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

4.8

50.9

119

226

H04AA01

ATC

glucagon; nasal, parenteral

2.8

50.8

268

880

I20.19

ICD-10 Finland

Angina angiospastic

4.7

50.8

122

237

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.2

50.2

137

295

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.8

50.2

251

801

I20.08

ICD-10 Finland

Unstable angina

5.7

50.1

152

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

49.8

483

2089

FXG00

NOMESCO Finland

Insertion and use of IABP

5.7

49.7

150

ANB

Coronary thrombectomy

5.5

49.6

160

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

2.6

49.5

290

1005

S18

ICPC

Laceration/cut

1.2

49.5

8979

71041

WX002

NOMESCO Finland

Sedation and analgesia

1.3

49.4

3551

25004

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

49.3

1404

8350

296

Kela drug reimbursment

Rivaroxaban for the treatment of coronary heart disease

8.9

49.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

49.1

2781

18870

NFQ20

NOMESCO Finland

Amputation of femur

2.8

48.8

257

843

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

5.0

48.7

108

196

I44.1

ICD-10 Finland

Atrioventricular block, second degree

2.0

48.2

556

2562

GD1LA

NOMESCO Finland

2.3

48.1

361

1405

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.4

48.1

125

259

Z2446

NOMESCO Finland

Social worker

1.7

48.0

993

5465

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

47.9

902

4842

TFN04, ,

NOMESCO Finland

3.7

47.8

158

391

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.1

47.8

204

595

SPAT1252

SPAT

Overall medication plan or its review

1.5

47.8

1434

8628

B04AB02, ,

ATC

2.0

47.7

501

2232

WW502

NOMESCO Finland

Autotransfusion

3.4

47.4

176

471

A02BC05

ATC

esomeprazole; systemic

1.3

47.2

7047

54460

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

47.1

1326

7864

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.5

46.7

163

419

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

4.8

46.4

107

201

A06AD11

ATC

lactulose; oral

1.3

46.0

3355

23642

TK810

NOMESCO Finland

Hemofiltration

3.5

45.7

160

412

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2.4

45.6

334

1286

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

45.6

920

5029

N02AA05

ATC

oxycodone; systemic

1.3

45.6

4082

29597

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.9

45.4

222

700

ZXA05

NOMESCO Finland

Left side

1.3

45.1

4697

34726

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

3.0

45.1

207

630

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

2.9

45.0

216

674

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.1

44.9

192

561

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

44.8

6519

50149

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

44.7

3132

21933

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.5

44.6

160

419

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.9

44.5

567

2703

A02BC03

ATC

lansoprazole; oral

1.3

44.5

5246

39370

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

4.8

44.5

103

194

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.8

44.3

654

3269

ZXA00

NOMESCO Finland

Right side

1.3

44.3

5014

37442

SPAT1310

SPAT

Counselling related to known health issue

1.3

44.1

5334

40148

3AC01, ,

NOMESCO Finland

3.0

44.0

200

605

FN2FT, ,

NOMESCO Finland

13.3

43.9

ANA

Coronary roablation

7.4

43.8

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

4.0

43.3

127

289

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

43.2

1333

8062

WX730

NOMESCO Finland

Conventional respirator

2.3

43.1

341

1359

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.0

42.7

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

5.3

42.6

153

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

42.5

1332

8082

K99

ICPC

Cardiovascular disease other

1.8

42.5

612

3036

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.0

42.3

497

2305

3013

Kela drug reimbursment

Rivaroxaban for the treatment of coronary artery disease

6.3

42.3

104

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

42.2

5078

38156

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

42.1

945

5308

I70.0

ICD-10 Finland

Atherosclerosis of aorta

3.3

42.1

163

448

FNG10

NOMESCO Finland

Embolectomy of coronary artery

5.4

42.1

145

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.1

42.0

404

1743

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.7

41.9

804

4336

N06AX11

ATC

mirtazapine; oral

1.3

41.9

5690

43356

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

7.7

41.8

N30.0

ICD-10 Finland

Acute cystitis

1.3

41.8

2725

18864

E86

ICD-10 Finland

Volume depletion

1.8

41.7

601

2982

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

5.4

41.7

143

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

41.4

940

5296

NGQ20

NOMESCO Finland

Amputation of lower leg

3.2

41.3

171

490

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

2.6

41.3

252

892

ZPB22

NOMESCO Finland

Autograft of vein

3.3

41.2

158

432

I22.89

ICD-10 Finland

recurrent infarction with other location unspecified coronary artery status

18.6

41.2

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

41.1

667

3432

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

3.0

41.0

187

567

K28

ICPC

Limited function/disability (K)

1.9

41.0

533

2559

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.8

40.9

213

695

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.1

40.8

378

1606

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

40.8

785

4237

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

40.8

2658

18393

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

40.8

966

5500

SPAT1260

SPAT

Consultation of another employee

1.3

40.7

3061

21627

N17.8

ICD-10 Finland

Other acute renal failure

2.4

40.7

297

1143

SPAT1234

SPAT

Support of social functional capacity

1.6

40.7

1113

6555

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.6

40.4

877

4886

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

40.3

895

5015

A02BA02

ATC

ranitidine; systemic

1.3

40.3

3676

26664

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

40.3

3866

28228

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

40.1

1417

8812

TK820

NOMESCO Finland

Peritoneal dialysis

4.1

40.0

113

250

160

Kela drug reimbursment

exenatide

2.2

39.9

345

1427

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

39.9

691

3623

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

39.9

3741

27230

C01AA05

ATC

digoxin; systemic

1.4

39.7

2104

14084

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

2.5

39.6

266

986

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

39.6

1108

6559

I51.8

ICD-10 Finland

Other ill-defined heart diseases

10.4

39.5

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.9

39.4

484

2280

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

39.2

648

3352

N03AX12

ATC

[U] gabapentin; oral

1.3

39.1

2638

18338

CKC12

NOMESCO Finland

Photocoagulation of retina

1.7

39.1

734

3936

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

39.0

6780

52962

C07AB03

ATC

atenolol; systemic

1.5

39.0

1278

7825

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

39.0

660

3437

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

39.0

741

3986

SPAT1255

SPAT

Intravenous administration of medicine

1.5

38.8

1267

7751

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

38.8

2322

15851

SPAT1229

SPAT

Assessment of need for aid

1.4

38.7

1569

10018

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

38.6

3131

22343

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.9

38.5

485

2304

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.3

38.5

102

215

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

38.1

1784

11690

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

4.3

38.1

101

213

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

3.9

38.0

113

260

PD4DG

NOMESCO Finland

Very extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.4

37.9

138

365

M10

ICD-10 Finland

Gout

1.6

37.8

987

5750

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

37.6

3205

23014

R60.0

ICD-10 Finland

Localized oedema

1.3

37.4

2484

17217

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.6

37.4

935

5390

C10AB02

ATC

bezafibrate; oral

2.2

37.3

311

1267

J01MA14

ATC

moxifloxacin; systemic

1.4

37.3

1564

10048

I95.9

ICD-10 Finland

Hypotension, unspecified

2.1

37.1

356

1534

XF640, ,

NOMESCO Finland

1.8

36.9

563

2843

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

36.6

687

3683

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.9

36.2

109

253

FNC60

NOMESCO Finland

Aorto-coronary venous bypass with six distal anastomoses

12.9

36.2

C09BA02

ATC

enalapril and diuretics; systemic

1.4

36.1

1721

11308

N083, E102,

ICD-10 Finland

8.8

36.1

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3012544) pH of Venous blood

4151

20487

2.03

319.89

5.5

3.7

7.37

7.38

3.52

2607

12039

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

12831

89513

1.76

318.81

6.6

6.8

12.35

12.56

umol/l

1.12

12341

85263

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4820

25150

1.95

316.43

2.0

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3928

18058

2.19

307.65

10.2

6.6

12.82

11.00

mmol/l

34.01

3750

17110

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3672

16299

2.25

307.65

4.1

3.0

368.25

227.02

ng/l

29.58

3437

14995

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6018

30491

2.10

307.65

3.7

2.6

2.22

2.25

g/l

5.49

5624

27899

(3003396) Base excess in Arterial blood by calculation

4980

23276

2.22

307.65

9.0

7.2

0.74

0.98

mmol/l

3.22

4029

19216

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9458

55913

1.96

307.65

2.7

2.2

242.10

227.07

u/l

0.88

8964

52578

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8093

48172

1.84

307.65

2.9

2.4

3.12

2.95

mg/l

6.85

7097

41146

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12040

68930

2.36

307.65

7.9

4.0

189.61

66.84

ng/l

4.99

10335

54356

(3016502) Oxygen saturation in Arterial blood

4581

20990

2.24

307.65

9.3

7.5

94.89

95.32

3.85

4412

20267

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6341

33361

2.03

307.65

2.2

2.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4162

19224

2.19

307.65

10.0

8.0

118.81

120.90

g/l

8.36

4073

18786

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11658

61405

2.62

307.65

4.5

3.3

3031.66

1591.89

ng/l

81.00

10734

53473

(3022948) Iron [Moles/volume] in Serum or Plasma

6280

32453

2.07

307.65

3.7

2.6

10.77

12.30

umol/l

54.46

5893

29891

(3032080) INR in Blood by Coagulation assay

13937

87978

2.30

307.65

21.4

19.1

1.35

inr

0.14

12216

74139

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4916

16297

3.25

307.65

3.2

2.3

9.18

6.99

ug/l

7.36

4333

13983

(3023368) Bacteria identified in Blood by Culture

9340

55453

1.94

307.65

5.5

4.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5685

28440

2.10

307.65

2.4

2.0

30.76

29.87

18.38

5537

27665

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6102

33568

1.90

307.65

2.0

1.7

1.42

1.53

mg/l

1.51

4964

26599

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5725

28368

2.13

307.65

3.8

2.6

19.57

22.01

35.31

5388

26075

(3027801) Oxygen [Partial pressure] in Arterial blood

5008

23420

2.22

307.65

9.1

7.2

11.36

12.02

kpa

17.89

4795

22466

(3013826) Glucose [Moles/volume] in Serum or Plasma

14826

100897

2.13

307.65

8.4

5.3

7.37

6.87

mmol/l

107.86

14461

96450

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7711

35171

2.55

307.65

8.5

3.9

883.25

421.15

ng/l

14.79

7338

30198

(3019977) pH of Arterial blood

5018

23404

2.23

307.65

9.1

7.2

7.42

0.73

2859

12854

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5009

23437

2.22

307.65

9.1

7.2

4.98

5.09

kpa

12.43

4795

22496

(3014576) Chloride [Moles/volume] in Serum or Plasma

5071

27294

1.89

300.97

9.6

6.9

104.25

104.26

mmol/l

0.04

5064

27279

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4512

23385

1.94

299.98

2.1

1.9

—

(3002032) Base excess in Venous blood by calculation

3958

19689

2.00

295.77

5.5

3.7

1.51

1.80

mmol/l

5.15

3464

17213

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4036

20228

1.99

295.19

5.4

3.7

5.79

5.82

kpa

0.97

3944

19749

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5433

30309

1.83

285.51

3.3

0.82

0.81

mmol/l

1.05

5094

28268

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1875

6995

2.56

280.11

3.2

2.8

0.35

iu/ml

0.07

1133

3804

(3014111) Lactate [Moles/volume] in Serum or Plasma

3603

17839

1.99

270.31

9.8

7.0

1.43

1.38

mmol/l

2.00

3528

17450

(3004451) EKG impression Narrative

578

1018

5.24

268.53

1.5

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2739

12393

2.14

261.40

8.0

6.7

24.09

24.57

mmol/l

8.20

2636

11873

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4600

25021

1.84

258.35

9.0

5.7

1.11

1.03

mmol/l

48.32

4315

23145

(3000991) Gas panel - Venous blood

3420

16992

1.98

252.37

11.8

8.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12567

90398

1.64

244.59

11.2

7.4

1.20

1.21

mmol/l

82.16

11036

77387

(3001122) Ferritin [Mass/volume] in Serum or Plasma

10000

68161

1.62

240.57

4.2

3.1

158.91

165.74

ug/l

1.42

9228

62200

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11477

81249

1.61

233.17

10.3

6.7

1.19

1.21

mmol/l

74.52

10746

74589

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2710

12735

2.06

232.13

12.0

9.1

0.62

0.63

0.25

2686

12659

(3027945) Reticulocytes/Erythrocytes in Blood

4450

24652

1.80

231.94

2.5

1.88

1.77

11.50

3955

21679

(3024354) Oxygen [Partial pressure] in Venous blood

3338

16888

1.93

231.73

4.4

3.0

4.51

4.43

kpa

1.37

3259

16424

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2770

13157

2.04

230.30

11.6

8.9

1.31

1.32

0.19

2745

13071

(3014007) Fractional oxyhemoglobin in Arterial blood

2741

13154

2.01

220.80

12.0

9.0

93.49

93.74

1.30

2722

13122

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2443

11321

2.07

216.32

12.4

9.4

15.74

15.98

3.75

2375

10930

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2562

12129

2.03

213.87

11.5

8.7

24.00

24.29

mmol/l

3.91

2469

11800

(3020682) Albumin/Creatinine [Ratio] in Urine

9055

61906

1.56

202.29

4.8

4.2

18.00

8.51

mg/mmol

31.66

6187

39339

(3012516) Albumin [Mass/volume] in Urine

8831

60415

1.55

193.98

4.0

3.5

91.06

48.67

mg/l

23.83

6364

39602

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2536

12373

1.97

193.11

10.8

7.5

24.38

24.80

mmol/l

6.66

2519

12265

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2154

9997

2.05

188.47

1.6

1.7

1.66

1.55

g/l

6.00

1882

8473

(3026008) Bacteria identified in Urine by Culture

8106

54895

1.54

183.09

4.0

3.6

—

(3009508) Creatinine [Moles/volume] in Urine

8859

61353

1.53

179.26

3.9

3.5

6.95

7.50

mmol/l

32.17

7416

50828

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1675

7226

2.19

176.82

2.6

2.2

710.04

621.95

ug/l

0.43

1615

6867

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10542

75891

1.51

176.57

3.5

2.9

—

estimate

—

(3023520) Reticulocytes [#/volume] in Blood

3489

19328

1.75

176.01

2.6

70.30

67.71

e9/l

4.21

2608

14394

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2304

11248

1.95

174.00

5.6

3.8

23.81

24.18

mmol/l

6.25

2270

11087

(3024561) Albumin [Mass/volume] in Serum or Plasma

11050

80791

1.50

168.21

6.4

5.2

33.70

34.72

g/l

62.49

10327

75123

(3006315) Basophils [#/volume] in Blood

11109

81348

1.50

167.54

6.5

6.2

0.04

e9/l

1.09

9425

68710

(3004119) Hemoglobin [Mass/volume] in Venous blood

2468

12500

1.89

166.41

4.7

3.2

122.28

128.49

g/l

34.08

2377

12164

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4073

23921

1.67

164.51

3.7

4.4

250.69

247.25

u/l

0.64

3840

22600

(3001604) Monocytes [#/volume] in Blood

11051

81020

1.49

164.25

6.5

6.1

0.68

0.63

e9/l

22.33

9373

68368

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2553

13125

1.86

164.14

4.8

3.7

5.12

5.14

kpa

0.46

2455

12412

(3019198) Lymphocytes [#/volume] in Blood

11232

82633

1.49

163.98

6.6

6.2

1.82

1.87

e9/l

0.95

9745

71461

(3013115) Eosinophils [#/volume] in Blood

11320

83419

1.49

163.85

6.7

6.4

0.21

0.20

e9/l

7.56

9752

71513

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1865

8624

2.04

163.72

2.0

1.9

2.25

2.22

ug/l

0.04

1646

7540

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7436

50475

1.51

159.85

3.2

3.3

41.20

35.73

u/l

2.24

6975

47157

(3009343) pH of Capillary blood

2481

12775

1.85

158.33

4.8

3.7

7.41

7.42

3.81

2168

10661

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15699

124326

1.56

157.30

9.8

8.7

84.85

82.03

u/l

7.32

15065

117561

(3006504) Eosinophils/Leukocytes in Blood

10312

75033

1.47

155.64

6.9

6.5

2.83

2.85

0.30

9692

69827

(3019069) Monocytes/Leukocytes in Blood

10338

75265

1.47

155.54

7.0

6.6

9.17

9.21

0.73

9711

70035

(3031040) Bacteria [#/volume] in Urine by Automated count

13969

108000

1.51

155.21

6.4

5.3

1703.26

1776.87

e6/l

0.04

283

1787

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2234

11227

1.89

153.54

4.6

3.5

1.84

1.87

mmol/l

0.09

1656

8226

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7867

54384

1.49

152.77

3.1

2.7

57.51

66.75

u/l

3.73

7385

50152

(3022096) Basophils/Leukocytes in Blood

10298

75101

1.47

152.29

7.0

6.5

0.62

0.65

9.57

9680

69912

(3013650) Neutrophils [#/volume] in Blood by Automated count

12069

90806

1.47

151.79

8.9

9.6

4.84

4.35

e9/l

66.97

10369

77911

(3002582) Erythrocytes [#/volume] in Urine

8521

60170

1.47

146.84

4.4

3.7

77.50

109.08

e6/l

2.24

6854

46762

(3018010) Neutrophils/Leukocytes in Blood

10213

74722

1.46

146.02

6.7

6.4

60.88

58.73

58.00

9761

70952

(3002030) Lymphocytes/Leukocytes in Blood

10404

76402

1.46

145.78

6.9

6.5

23.54

25.79

76.12

9867

71925

(3027273) Bicarbonate [Moles/volume] in Venous blood

1923

9364

1.94

144.93

5.0

3.4

24.89

25.19

mmol/l

3.03

1859

9094

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1871

9103

1.94

141.19

5.9

4.9

1.61

1.59

0.46

1782

8663

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2595

14013

1.77

140.28

1.7

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5440

35415

1.52

137.92

1.9

1.8

1161.20

1151.33

nmol/l

0.31

4190

26441

(3007930) Methemoglobin/Hemoglobin.total in Blood

1736

8325

1.96

136.48

6.1

5.1

0.87

0.86

0.39

1649

7892

(3018405) Lactate [Moles/volume] in Arterial blood

1437

6439

2.09

136.40

4.7

4.0

1.47

1.40

mmol/l

1.12

1402

6314

(3033658) Prothrombin time (PT) actual/Normal

6389

43105

1.49

135.82

5.6

4.3

81.19

83.90

15.14

6250

42262

(3018095) Leukocytes [#/volume] in Urine

9062

65431

1.44

134.98

5.1

4.3

133.14

122.25

e6/l

0.33

6965

47974

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2059

10576

1.84

130.96

3.8

2.7

1.20

1.19

0.13

2049

10534

(42870588) Differential panel, method unspecified - Blood

7980

56611

1.44

128.80

6.5

6.2

—

4.45

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2016

10338

1.84

128.80

5.8

4.0

47.10

46.43

0.59

1990

10203

(3007853) Bacteria identified in Skin by Aerobe culture

3407

20244

1.62

127.56

2.3

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2029

10482

1.83

126.44

3.8

2.7

0.63

0.62

0.49

2020

10451

(3026493) Urate [Moles/volume] in Serum or Plasma

6697

46135

1.46

125.59

3.5

3.0

384.52

360.78

umol/l

50.26

5809

39736

(3028626) Oxygen [Partial pressure] in Capillary blood

1139

4812

2.20

125.44

3.7

3.0

7.82

7.88

kpa

0.60

1120

4693

(3030467) Casts [#/volume] in Urine by Automated count

7413

52149

1.44

123.80

4.2

3.6

0.53

0.47

e6/l

0.94

5819

39212

(3020891) Body temperature

1839

9275

1.86

123.62

5.9

4.4

36.90

°c

0.19

1808

9187

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6165

41905

1.46

123.50

3.1

2.6

—

(3000850) Epithelial cells [#/volume] in Urine

6199

42296

1.46

121.26

3.5

2.9

4.49

4.55

e6/l

0.18

5741

38551

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10653

80269

1.40

118.73

2.5

2.3

92.09

93.88

pmol/l

3.48

6023

43692

(36304419) Bacteria [Presence] in Urine

6967

48738

1.43

118.58

4.1

3.5

5.44

358.86

estimate

1.13

273

(3037467) Urinalysis macro (dipstick) panel - Urine

13937

110099

1.43

117.90

6.0

5.0

2.13

2.26

0.09

172

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1482

7068

1.96

117.76

3.9

2.9

24.55

24.74

mmol/l

0.93

1462

6939

(3044889) 12 lead EKG panel

13917

110081

1.42

115.46

6.8

4.6

11799.92

2757.59

0.34

277

(3018418) pH of Serum or Plasma

7595

54419

1.41

110.91

5.9

4.4

7.39

7.40

5.48

5756

39354

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1320

6216

1.98

108.54

1.3

—

(3021901) Oxygen saturation in Capillary blood

1004

4272

2.18

108.33

3.8

3.0

88.77

89.17

0.99

988

4147

(3043409) Potassium [Moles/volume] in Arterial blood

1184

5382

2.04

107.46

5.2

4.3

4.00

3.90

mmol/l

7.76

1167

5338

(3047181) Lactate [Moles/volume] in Blood

1226

5647

2.02

107.28

6.6

5.9

1.44

1.33

mmol/l

2.67

1097

5009

(3042936) Bacteria identified in Isolate by Culture

4052

25987

1.50

105.72

2.6

2.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

17680

147246

1.55

105.28

31.5

19.5

27.71

28.42

mg/l

2.18

16341

125462

(1616796) Gas panel - Central venous blood

1010

4401

2.12

102.48

5.1

3.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

7523

54346

1.39

102.25

2.0

1.8

18.79

19.97

nmol/l

8.24

6560

45633

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16448

135177

1.46

102.15

5.9

4.5

1.36

1.29

mmol/l

27.15

15352

120969

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2423

14053

1.63

97.83

5.6

3.8

129.51

95.25

ng/l

30.22

2099

11847

(3013512) EKG study

8348

62087

1.35

91.32

6.3

4.0

0.68

0.75

0.33

167

(40767503) Oxygen content in Capillary blood by calculation

927

4100

2.09

90.29

3.4

2.7

15.69

16.20

4.84

911

4009

(3020630) Protein [Mass/volume] in Serum or Plasma

2875

17707

1.54

89.05

2.4

2.7

65.26

66.04

g/l

6.36

2602

16052

(3022313) Gas panel - Capillary blood

1657

8925

1.73

88.11

5.0

3.8

—

(3024928) Oxygen saturation in Venous blood

1033

4808

1.99

87.41

4.1

2.9

62.84

60.12

3.38

987

4611

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3076

19368

1.51

85.60

2.6

2.8

8.54

10.21

umol/l

4.95

2698

17141

(3039000) Anion gap in Blood by calculation

885

3948

2.07

84.17

7.4

6.8

11.65

11.25

mmol/l

2.93

803

3559

(3018572) Chloride [Moles/volume] in Blood

885

3948

2.07

84.17

7.4

6.8

104.87

104.90

mmol/l

0.08

804

3559

(3027315) Oxygen [Partial pressure] in Blood

888

3978

2.06

83.50

5.6

4.1

8.33

8.40

kpa

0.56

870

3869

(3012501) Base excess in Blood by calculation

883

3957

2.06

82.94

5.6

4.1

2.52

2.65

mmol/l

0.72

611

2718

(3013290) Carbon dioxide [Partial pressure] in Blood

883

3959

2.06

82.83

5.6

4.1

4.95

5.00

kpa

1.08

865

3851

(3026782) Osmolality of Urine

5213

36529

1.38

80.61

3.7

3.1

518.73

542.73

mosm/kgh2o

14.57

4672

32112

(3015736) pH of Urine

9001

68599

1.32

79.52

4.4

3.8

6.26

6.25

0.55

4928

36958

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

980

4638

1.95

78.91

2.3

3.57

3.64

g/l

0.74

942

4442

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1330

6944

1.78

78.54

2.0

1.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16839

140834

1.41

77.49

10.0

7.3

43.73

40.30

mmol/mol

297.82

15948

129294

(3035350) Ketones [Presence] in Urine by Test strip

10944

85916

1.31

77.20

5.1

4.3

7.79

3.57

estimate

1.24

2427

18757

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1407

7509

1.74

76.94

2.2

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9410

72415

1.31

76.41

2.7

2.4

—

(3009261) Glucose [Presence] in Urine by Test strip

10989

86390

1.31

76.34

5.1

4.3

0.96

0.34

estimate

0.45

2151

17496

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2925

18621

1.48

76.31

5.1

3.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4736

32910

1.39

76.31

3.7

3.3

1.12

1.24

e6/l

0.51

2765

18104

(3021601) Nitrite [Presence] in Urine by Test strip

10800

84809

1.31

75.08

5.0

4.2

0.00

estimate

0.12

2359

18182

(3010421) pH of Blood

1152

5922

1.80

71.53

5.4

3.7

7.41

0.10

1135

5824

(3028271) Lactate [Moles/volume] in Capillary blood

686

2960

2.13

71.13

2.3

1.8

1.70

1.74

mmol/l

0.45

671

2872

(3022806) Fractional oxyhemoglobin in Capillary blood

550

2205

2.28

68.34

2.2

1.8

88.60

89.09

0.87

539

2173

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2509

15855

1.49

67.21

2.9

2.6

40.96

49.22

u/l

0.62

2096

13450

(3006184) Hemoglobin [Mass/volume] in Capillary blood

972

4856

1.84

66.16

2.9

2.3

124.83

128.27

g/l

3.81

799

3693

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

908

4442

1.88

66.02

2.5

2.3

174.21

111.28

ug/min

2.85

551

2585

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4329

30297

1.36

65.04

3.8

3.4

2.10

2.13

e6/l

0.08

2357

15410

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

14004

115050

1.30

63.22

5.2

4.6

17.18

13.94

mm/h

77.43

13032

106291

(3036489) Thrombin time

1082

5671

1.76

62.74

2.2

1.9

22.27

21.48

1.78

998

5128

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

831

4025

1.90

62.27

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

831

4025

1.90

62.27

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16711

141018

1.35

60.13

6.9

5.3

1.26

1.42

mmol/l

307.65

15755

127835

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

929

4720

1.81

59.80

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1354

7639

1.64

59.69

2.7

3.3

44.11

48.36

mg/l

0.70

1113

6484

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

824

4043

1.87

59.31

2.5

2.3

222.76

208.47

4.10

786

3838

(3034860) Kappa light chains.free [Mass/volume] in Serum

1353

7650

1.64

59.12

2.7

3.3

104.63

63.03

mg/l

0.50

1110

6489

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

935

4787

1.80

58.66

1.5

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1342

7595

1.63

58.40

1.4

1.5

20.17

16.77

iu/ml

0.27

162

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1232

6840

1.66

57.79

2.7

3.2

3.32

6.34

ratio

0.82

715

4030

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1246

6940

1.66

57.72

5.2

3.9

24.59

24.86

mmol/l

2.30

1138

6267

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11593

93546

1.27

57.24

3.9

3.4

66.22

57.42

u/l

12.05

10786

86059

(3021589) Normoblasts [#/volume] in Blood

8880

69437

1.27

57.11

16.8

12.7

0.00

e9/l

0.07

7136

56502

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

616

2775

2.03

56.91

6.7

6.0

12.36

12.19

mg/l

0.41

571

2537

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

944

4891

1.78

56.87

1.5

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

530

2283

2.12

55.18

10.3

9.5

7.90

7.42

mmol/l

2.08

441

1878

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16784

142228

1.33

54.53

7.0

5.4

3.79

4.43

mmol/l

307.65

15917

130030

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

862

4408

1.80

54.25

2.3

2.1

87.77

89.06

0.90

833

4247

(3019230) Fractional oxyhemoglobin in Venous blood

795

3992

1.83

53.12

3.7

2.6

64.56

60.76

4.73

790

3975

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13415

110630

1.26

52.63

4.4

4.1

15.11

15.08

pmol/l

0.95

12217

99348

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2114

13551

1.45

51.74

3.8

2.9

50.89

61.36

ml/min/173m2

31.53

1046

5932

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1138

6381

1.64

51.23

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5138

38024

1.29

49.86

1.9

1.8

36989675.14

26989421.30

pmol/l

0.52

4185

30694

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

15980

135056

1.29

48.72

5.8

5.2

2.08

2.03

mu/l

2.85

14764

122226

(3011397) Hemoglobin [Presence] in Urine by Test strip

5391

40240

1.28

48.66

4.6

4.1

0.16

0.26

0.41

507

(3023183) Ammonium ion [Moles/volume] in Plasma

804

4175

1.77

48.00

2.1

2.4

30.18

33.34

umol/l

3.21

702

3699

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2188

14329

1.42

47.42

1.9

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1995

12857

1.44

47.21

2.0

1.6

—

(40758558) Short blood count panel - Blood

6307

48254

1.26

45.70

6.9

6.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

17854

153509

1.34

45.66

40.9

23.7

139.32

139.58

mmol/l

31.28

17660

150420

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

167

445

3.40

45.27

10.5

7.6

6.04

5.97

kpa

0.45

138

392

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2141

14125

1.41

44.32

2.1

2.4

381.60

385.08

nmol/l

0.22

1966

13004

(3023103) Potassium [Moles/volume] in Serum or Plasma

17857

153719

1.34

43.70

41.3

23.9

4.06

4.01

mmol/l

108.15

17654

150416

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17012

145518

1.30

43.19

8.2

6.3

2.02

2.55

mmol/l

307.65

16103

132562

(3044242) Glucose [Moles/volume] in Arterial blood

296

1107

2.43

43.16

1.9

2.0

8.66

8.18

mmol/l

1.24

296

1107

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2584

17672

1.36

42.94

2.1

2.2

0.19

0.20

g/l

3.81

2340

16345

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

763

4049

1.73

42.19

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

908

5056

1.65

41.91

3.6

2.7

2.15

1.70

mg/l

30.37

829

4501

(3006576) Bicarbonate [Moles/volume] in Blood

198

620

2.90

41.05

7.0

6.2

25.53

24.90

mmol/l

1.22

168

565

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

908

5090

1.64

40.80

1.5

6.97

15.97

iu/ml

3.52

110

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8803

70429

1.22

40.57

2.6

2.4

76.07

79.24

nmol/l

20.81

7740

62047

(46235355) HIV 1 and 2 tests - Meaningful Use set

2343

15927

1.37

40.28

1.9

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

535

2592

1.88

40.04

2.4

2.3

1.36

1.13

g/24h

1.39

329

1501

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

667

3465

1.76

39.75

1.5

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16720

143133

1.27

39.04

6.8

5.8

6.48

6.11

mmol/l

157.92

15312

128903

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

381

1663

2.09

38.41

1.2

1.3

1.46

1.45

nmol/l

0.03

349

1495

(3003434) Protein [Mass/volume] in Pleural fluid

656

3429

1.75

38.27

1.5

28.22

41.14

g/l

0.84

576

3114

(3008037) Lactate [Moles/volume] in Venous blood

914

5215

1.61

38.21

4.9

3.3

1.65

1.64

mmol/l

0.08

892

5099

(3014051) Protein [Presence] in Urine by Test strip

5595

42941

1.24

37.73

3.7

3.2

0.12

0.08

0.59

193

1422

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

660

3478

1.73

37.42

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

498

2412

1.88

37.32

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

637

3332

1.75

37.07

1.5

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

646

3396

1.74

36.94

1.3

75.56

160.00

titre

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

640

3390

1.73

35.63

1.3

190.11

279.42

titre

0.70

266

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

491

2405

1.86

35.55

1.5

—

(3017569) Oxygen content in Arterial blood

284

1141

2.26

35.28

2.0

2.3

15.37

15.76

1.11

284

1141

(3038071) Oxygen [Partial pressure] in Mixed venous blood

138

391

3.20

34.05

11.1

7.5

5.67

5.51

kpa

0.24

138

391

(3000012) Reticulocyte production index

610

3231

1.72

33.97

2.1

2.2

0.93

0.90

0.54

459

2248

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

387

1783

1.98

33.68

3.4

2.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

566

2949

1.75

33.42

1.5

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

7497

59848

1.20

33.00

3.4

3.6

2.34

2.35

mmol/l

9.22

6698

53690

(3019150) Specific gravity of Urine by Refractometry

4923

37720

1.23

32.81

5.4

4.6

1.30

1.10

kg/l

0.32

3580

25596

(3037522) Nuclear Ab [Titer] in Serum

2667

19004

1.30

32.74

1.4

1.3

530.27

486.59

titre

0.61

623

4214

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2288

15965

1.33

32.65

3.1

2.6

0.54

0.47

e6/l

0.93

2224

15437

(3027456) Digoxin [Moles/volume] in Serum or Plasma

871

5114

1.56

32.20

3.3

0.84

0.81

nmol/l

1.37

689

4089

(3028026) IgM [Mass/volume] in Serum or Plasma

1424

9240

1.42

31.98

1.8

2.0

1.19

1.37

g/l

2.02

1294

8370

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

436

2135

1.86

31.63

1.4

1.3

3.08

2.41

nmol/l

0.10

420

2042

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

442

2178

1.85

31.44

1.4

1.3

0.16

0.28

nmol/l

1.99

179

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7861

63222

1.20

31.41

5.3

4.4

1.19

0.48

estimate

0.75

1959

14835

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

765

4384

1.60

31.39

1.6

1.5

1.20

1.18

g/l

0.85

732

4174

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

926

5559

1.53

30.95

1.9

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

343

1562

2.00

30.89

1.6

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

771

4451

1.58

30.67

5.3

3.4

8.12

7.72

mmol/l

2.97

751

4353

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

744

4267

1.59

30.43

1.6

1.5

0.24

g/l

1.96

710

4045

(3052851) Hemolysis interference index of Serum or Plasma

859

5125

1.53

29.54

4.6

3.5

1.91

1.96

index

0.11

510

2595

(3017181) Myelocytes/Leukocytes in Blood

2217

15623

1.31

29.31

4.2

0.84

0.96

1.57

787

5188

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1358

8876

1.41

29.20

2.1

2.4

7.70

7.41

g/l

7.85

1225

7987

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1353

8849

1.41

28.98

2.1

2.4

3.74

3.75

g/l

0.14

1221

7969

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1355

8869

1.40

28.89

2.1

2.4

4.15

4.18

g/l

0.63

1223

7990

(3036525) Urea [Moles/time] in 24 hour Urine

103

5.27

28.89

3.0

3.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

2113

14837

1.32

28.62

4.0

4.1

0.67

0.71

0.16

750

4946

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

13842

117392

1.19

28.57

37.8

24.1

14.26

13.89

142.93

13724

115755

(3023199) Leukocytes [#/volume] in Pleural fluid

555

3007

1.68

28.48

1.4

1.5

3320.36

2762.37

e6/l

0.13

399

2139

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1195

7676

1.43

28.33

2.1

2.4

9.96

10.29

g/l

1.77

1053

6694

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

387

1894

1.86

28.18

1.4

1.3

0.25

0.21

nmol/l

0.31

311

1553

(3025941) Bacteria identified in Stool by Culture

1156

7397

1.43

27.99

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

2114

14892

1.31

27.94

4.2

4.3

0.09

0.11

1.04

692

4495

(3005719) IgG [Mass/volume] in Serum or Plasma

1718

11758

1.35

27.75

2.6

2.9

10.71

10.75

g/l

0.13

1598

10787

(3022493) Free Hemoglobin [Mass/volume] in Plasma

204

797

2.32

27.18

5.4

3.3

103.95

913.40

mg/l

1.01

151

541

(3000330) Specific gravity of Urine by Test strip

1416

9448

1.38

26.88

4.3

3.8

1.02

ratio

1.64

1311

8563

(3025159) Blasts/Leukocytes in Blood

2106

14903

1.31

26.87

4.3

4.4

0.07

0.38

6.10

659

4251

(44806118) Parainfluenza type 4 nucleic acid detection

431

2219

1.77

26.59

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

431

2220

1.77

26.55

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

431

2220

1.77

26.55

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

431

2220

1.77

26.55

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

474

2528

1.71

25.82

3.4

2.4

105.49

105.55

mmol/l

0.12

467

2509

(3041354) Potassium [Moles/volume] in Venous blood

474

2528

1.71

25.82

3.4

2.4

4.17

4.10

mmol/l

3.45

467

2510

(40768797) Stomach Pathology biopsy report

3033

22573

1.25

25.59

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

611

3490

1.60

25.46

1.3

34.21

35.74

u/l

0.14

532

3002

(3037756) Immunofixation for Serum or Plasma

781

4726

1.51

25.15

1.5

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

4166

32105

1.21

25.11

5.4

4.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

106

309

3.10

25.08

7.4

6.8

10.06

10.42

0.99

106

309

(3033705) Calcium.ionized [Moles/volume] in Venous blood

466

2498

1.70

24.93

3.5

2.4

1.19

1.20

mmol/l

1.05

459

2480

(40757494) Bilirubin.total [Moles/volume] in Blood

220

929

2.15

24.36

2.1

2.2

23.33

29.77

umol/l

0.37

(3024891) Influenza virus A+B Ag [Presence] in Specimen

603

3476

1.58

24.18

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

17881

156000

1.24

24.17

41.8

26.1

99.04

84.73

umol/l

167.77

17686

153769

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1249

8313

1.38

24.03

2.1

2.4

3.04

2.92

g/l

3.60

1116

7426

(3003181) Sodium [Moles/volume] in Urine

646

3797

1.55

23.80

1.4

57.89

61.11

mmol/l

1.51

519

3073

(3012441) Differential panel - Pleural fluid

472

2580

1.67

23.49

1.4

1.5

—

0.80

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

355

1792

1.80

23.47

1.2

57.32

64.23

u/l

1.19

318

1551

(3029937) Albumin [Presence] in Urine by Test strip

6142

49247

1.18

23.44

5.4

4.4

0.00

estimate

0.16

1988

16179

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1427

9749

1.34

23.21

2.6

2.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

360

1832

1.79

23.17

1.4

1.3

—

nmol/l

—

(3022621) pH of Urine by Test strip

1808

12782

1.30

23.08

3.3

3.0

5.97

6.03

2.52

1364

9056

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

615

3602

1.56

23.03

1.4

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

5.80

22.95

14.6

9.7

371.77

173.38

e6/l

0.44

(3037121) Protein [Mass/volume] in Urine

976

6281

1.42

22.87

3.1

3.2

530.60

571.68

mg/l

0.16

480

2887

(3045414) Leukocytes [Presence] in Urine

2278

16629

1.26

22.52

2.4

2.2

0.01

estimate

0.10

351

3103

(3028308) Erythrocytes [#/volume] in Pleural fluid

484

2694

1.64

22.46

1.4

1.5

49473.82

61552.94

e6/l

0.49

289

1549

(3017704) Immunofixation for Urine

249

1136

1.99

22.46

1.3

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3399

25923

1.22

22.45

1.6

1.5

2.85

2.72

g/l

2.07

2014

15077

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

679

8985

0.67

22.41

2.3

2.2

3.25

3.52

ratio

6.35

554

7375

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17595

153469

1.22

22.38

16.4

13.2

27.57

25.73

u/l

6.48

17149

147977

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

286

1376

1.89

22.07

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

491

2763

1.62

21.81

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1120

7448

1.38

21.64

2.9

2.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

661

3995

1.51

21.44

1.2

—

(3045788) Cell count panel - Pleural fluid

439

2416

1.65

21.32

1.4

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

160

627

2.31

21.29

2.8

2.6

9.51

10.18

kpa

1.92

160

627

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1141

7631

1.37

21.28

2.3

2.5

0.66

1.02

g/l

3.44

969

6435

(42529406) Shigella sp [Presence] in Stool by Culture

661

4004

1.50

21.21

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

268

1284

1.89

20.97

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

121

421

2.60

20.80

5.6

5.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

159

628

2.29

20.79

2.8

2.6

5.01

4.93

kpa

0.43

159

628

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

653

3967

1.50

20.67

1.2

—

(3011985) Renin [Units/volume] in Plasma

410

2237

1.67

20.61

1.2

1.4

80.97

60.72

mu/l

1.01

369

1984

(3004775) Volume in Urine collected for unspecified duration

302

1512

1.81

20.58

2.3

693.41

677.30

0.25

199

990

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

503

2889

1.58

20.55

1.5

1.4

12.21

13.81

u/ml

0.19

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1174

7953

1.35

20.16

3.2

3.4

4.18

4.38

pmol/l

9.71

1055

7009

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

554

3269

1.54

20.11

2.0

1.5

0.94

0.86

nmol/l

1.15

447

2749

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

229

1057

1.96

20.04

1.1

1.2

10.48

9.70

mmol/l

1.79

214

971

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

967

6359

1.39

20.00

2.1

2.4

0.02

0.04

g/l

0.77

874

5657

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

668

4109

1.48

19.90

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

433

2423

1.62

19.72

1.7

1.4

162.29

153.97

au/ml

0.76

135

715

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13547

116081

1.15

19.29

40.4

25.5

330.15

331.80

g/l

78.64

13444

115252

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

267

1318

1.84

19.08

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

263

1294

1.84

19.00

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

212

973

1.98

18.89

1.3

1.35

1.21

nmol/l

0.72

156

717

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

474

2741

1.57

18.84

1.6

1.4

14.29

18.68

u/ml

—

(3036782) Glucose [Moles/volume] in Pleural fluid

410

2290

1.63

18.84

1.4

7.10

6.26

mmol/l

6.48

384

2134

(3016750) Collection duration of Urine

227

1068

1.93

18.82

2.3

2.2

500.13

496.88

min

0.17

158

770

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

929

6132

1.38

18.80

2.1

2.4

0.00

g/l

0.45

825

5321

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

876

5727

1.40

18.77

2.2

2.5

0.00

g/l

-0.00

820

5310

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

198

890

2.02

18.71

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

198

890

2.02

18.71

1.3

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

401

2235

1.63

18.59

1.7

2.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

419

2366

1.61

18.43

1.3

368.25

484.79

u/l

0.57

396

2247

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1253

8684

1.32

18.41

1.4

—

(40768806) Pleura Pathology biopsy report

448

2573

1.58

18.35

1.5

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

218

1022

1.93

18.28

1.2

1.3

118.37

96.52

u/l

1.58

189

854

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.68

18.24

5.0

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

761

4881

1.42

18.20

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

151

620

2.21

18.07

42.6

37.4

6.97

7.23

ug/l

0.83

137

540

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

723

4603

1.43

18.02

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

213

996

1.94

18.01

1.2

1.3

36.19

28.29

u/l

1.04

181

816

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2008

14810

1.25

17.96

5.9

4.0

1.21

1.23

mmol/l

13.33

1804

12649

(3051611) Lipemic interference index of Serum or Plasma

339

1827

1.68

17.92

4.7

3.5

12.41

12.71

index

0.23

221

963

(3007566) Smooth muscle Ab [Titer] in Serum

632

3935

1.46

17.74

1.2

104.66

135.43

titre

0.52

359

(21494755) Public health laboratory ask at order entry panel

482

6508

0.66

17.61

1.5

1.4

—

(3010813) Leukocytes [#/volume] in Blood

17881

156865

1.20

17.47

46.4

29.3

7.55

6.93

e9/l

96.43

17512

152249

(3035941) MCH [Entitic mass]

17875

156835

1.20

17.28

46.2

29.2

30.37

30.50

17.47

17705

154582

(3024731) MCV [Entitic mean volume] in Red Blood Cells

17875

156845

1.20

17.21

46.2

29.2

91.92

91.81

2.14

17708

154592

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

17875

156847

1.20

17.19

47.7

29.8

38.79

40.05

55.84

17704

154516

(3007461) Platelets [#/volume] in Blood

17872

156820

1.20

17.18

46.4

29.3

235.61

238.78

e9/l

7.78

17556

152864

(3026361) Erythrocytes [#/volume] in Blood

17875

156850

1.20

17.17

46.3

29.3

4.30

4.42

e12/l

157.99

17498

152183

(3044927) Protein electrophoresis panel - Urine

384

2161

1.61

17.16

1.3

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

17875

156867

1.20

17.05

46.8

29.5

129.18

133.87

g/l

257.74

17712

154658

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

415

2383

1.58

17.05

2.5

2.1

24.89

27.80

mg/l

0.59

160

860

(3034770) Mitochondria Ab [Titer] in Serum

624

3908

1.45

17.01

1.2

770.67

868.74

titre

0.15

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

402

2294

1.59

16.96

1.3

1.2

296.75

282.31

u/ml

0.33

246

1400

(3023419) Bacteria identified in Sputum by Culture

437

2550

1.56

16.75

2.1

2.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

464

6234

0.66

16.55

1.9

1.8

2.63

3.39

mmol/l

30.47

340

4542

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

293

1563

1.70

16.14

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

293

1563

1.70

16.14

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

293

1563

1.70

16.14

1.3

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

651

4154

1.43

16.06

1.9

14.31

12.21

mg/l

2.04

607

3848

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

211

1029

1.86

15.77

1.7

2.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

556

3461

1.46

15.68

5.4

5.2

2451.71

1082.66

iu/ml

0.37

534

(40768446) Kidney Pathology biopsy report

137

576

2.15

15.54

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

756

4982

1.38

15.49

1.6

29.47

26.11

u/ml

0.27

115

951

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

453

2718

1.51

15.33

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

230

1167

1.79

15.14

1.6

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

236

1210

1.77

15.00

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

224

1132

1.79

14.95

1.6

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

363

2087

1.58

14.90

1.2

1.3

240.71

342.24

pmol/l

1.22

293

1729

(43055442) Apixaban [Mass/volume] in Serum or Plasma

105

404

2.35

14.73

1.7

1.6

115.28

115.37

ug/l

0.00

327

(3041096) Erythrocytes [Presence] in Urine by Automated

5316

43333

1.14

14.71

4.8

3.8

0.41

0.32

estimate

0.18

1835

14065

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.62

14.53

6.1

6.2

408.25

441.76

umol/l

0.39

(3004716) Salmonella sp identified in Stool by Organism specific culture

758

5051

1.37

14.52

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3658

29129

1.16

13.96

1.3

1.75

1.81

u/ml

0.10

857

7208

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

947

6578

1.31

13.72

1.8

37.46

38.68

u/l

0.94

785

5651

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

16170

141317

1.14

13.71

30.9

19.5

68.23

73.75

ml/min/173m2

183.36

15448

132240

(3003129) Base excess in Capillary blood by calculation

395

2362

1.52

13.64

2.6

2.3

-0.03

0.45

mmol/l

1.58

375

2270

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4553

36903

1.14

13.50

3.0

3.2

2.47

2.46

mmol/l

1.82

3945

32928

(3042631) Mycobacterium sp identified in Specimen

460

2844

1.47

13.49

2.5

2.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

834

5763

1.32

12.56

1.8

1.7

9.41

7.82

iu/ml

0.50

191

1363

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7273

60918

1.12

12.42

2.2

1.9

1.37

1.32

mmol/l

3.48

6174

49589

(3048929) Epstein Barr virus Ab [Presence] in Serum

487

3095

1.43

12.39

1.3

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

519

3346

1.41

12.19

3.3

3.6

1.35

1.59

0.96

457

2950

(3019225) pH of Specimen

2286

17750

1.18

11.85

5.9

4.4

7.36

0.44

1766

12661

(3014271) Vancomycin [Susceptibility]

221

1195

1.68

11.73

3.2

3.0

—

(4024509) Urine culture

1106

7997

1.26

11.72

2.2

2.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

150

728

1.86

11.53

1.8

2.0

94.12

95.37

0.16

144

694

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

142

2313

0.55

11.42

1.2

0.53

0.64

ratio

2.98

417

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

751

5185

1.32

11.41

1.4

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

5.52

11.23

6.9

9.9

41.67

49.83

0.53

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

192

1012

1.72

11.22

1.6

1.5

8.63

6.99

u/l

0.50

159

793

(3035947) Staphylolysin Ab [Units/volume] in Serum

172

880

1.77

11.15

1.2

1.1

2.83

4.12

iu/ml

0.90

(3052592) Norovirus Ag [Presence] in Stool

363

2.22

11.03

1.4

1.3

—

(3014891) Appearance of Pleural fluid

341

2.25

10.96

1.4

1.6

—

(3012565) Volume of 24 hour Urine

163

826

1.79

10.93

2.3

2.2

1662.62

1903.79

2.33

141

710

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2649

20954

1.16

10.83

12.7

8.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

355

2188

1.47

10.69

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

925

1.73

10.69

1.2

88.92

82.28

1.32

(3000570) Elastase.pancreatic [Mass/mass] in Stool

775

5424

1.30

10.68

1.5

1.4

256.60

257.92

ug/g

0.06

481

3318

(3024522) Salmonella sp identified in Specimen by Organism specific culture

356

2203

1.47

10.51

1.4

—

(3017732) Neutrophils [#/volume] in Blood

2500

19744

1.16

10.42

3.3

5.35

4.85

e9/l

1.65

2089

16472

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

194

1048

1.68

10.39

2.4

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

361

2246

1.46

10.37

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

307

2.27

10.11

2.8

3.1

14.29

14.78

ml/dl

0.68

292

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

554

3727

1.35

10.10

1.2

12.00

16.52

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

180

961

1.70

10.09

1.1

117.45

85.25

u/l

2.24

160

840

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

423

2726

1.41

10.04

2.6

2.5

2387.75

4698.98

u/ml

0.27

178

(40761536) Microorganisms panel - Urine sediment

1678

12866

1.19

10.03

5.7

4.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

209

2.55

10.02

1.2

7.28

157405.96

nmol/l

0.72

169

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

178

950

1.70

10.00

1.1

48.24

25.69

u/l

1.92

157

824

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

340

2108

1.46

9.97

1.4

—

(36660697) Celiac disease serology panel - Serum

1370

10316

1.21

9.96

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

340

2111

1.46

9.90

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

976

10833

0.80

9.78

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

338

2102

1.46

9.76

1.4

—

(40768800) Prostate Pathology biopsy report

455

5573

0.73

9.73

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

641

4431

1.31

9.72

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

290

1755

1.50

9.61

1.4

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

131

654

1.81

9.31

28.6

30.4

101.16

111.01

ug/l

1.37

547

(3016650) Hepatitis A virus Ab [Presence] in Serum

352

2229

1.43

9.26

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

172

930

1.67

9.24

1.3

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

379

2434

1.41

9.22

1.6

0.76

0.88

g/l

1.44

310

1870

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

172

931

1.67

9.21

1.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

172

931

1.67

9.21

1.3

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

172

931

1.67

9.21

1.3

1.8

—

(3003694) ABO and Rh group [Type] in Blood

4923

40896

1.11

9.15

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

211

1206

1.58

9.09

1.2

125.00

162.50

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

211

1206

1.58

9.09

1.2

154.17

138.29

titre

0.12

211

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

301

1858

1.47

9.07

1.4

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1550

16337

0.84

9.04

2.2

2.3

11.71

12.94

nmol/l

7.85

1350

14428

(3035880) pH of Pleural fluid

225

1307

1.56

9.04

1.3

7.43

7.40

1.38

164

932

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

311

2.18

9.01

1.8

1.18

1.19

mmol/l

0.31

299

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1649

12746

1.18

8.98

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

143

742

1.74

8.94

1.3

2.98

3.53

mmol/l

1.27

129

682

(3035320) C reactive protein [Mass/volume] in Body fluid

217

1254

1.57

8.93

3.0

2.8

33.31

31.46

mg/l

0.27

169

931

(3016038) Potassium [Moles/volume] in Urine

228

1333

1.55

8.91

1.2

1.1

36.57

34.52

mmol/l

0.57

194

1138

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

235

2.35

8.72

2.5

2.8

73.15

66.03

mg/l

0.10

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

360

2321

1.41

8.60

1.0

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

340

2174

1.42

8.52

3.1

3.6

61.88

58.55

2.12

279

1847

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

134

693

1.75

8.50

1.5

82.31

96.02

umol/l

0.51

350

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

634

4461

1.29

8.48

1.6

1.5

17.32

4.78

iu/ml

0.53

130

960

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.41

8.40

7.6

9.6

—

(3048689) Calprotectin [Mass/mass] in Stool

2044

16154

1.16

8.39

2.1

2.2

195.61

162.94

ug/g

2.40

1630

12703

(3005532) Lymphocytes/Leukocytes in Pleural fluid

155

838

1.67

8.38

1.4

65.06

64.36

0.09

121

688

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

165

909

1.64

8.30

2.2

282.53

83.89

ug/min

0.88

213

(3006270) Folate [Moles/volume] in Blood

239

1443

1.50

8.10

1.3

1.2

305.04

328.80

nmol/l

0.98

175

1130

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

339

2189

1.40

8.06

1.1

718.19

6030.12

iu/ml

0.47

398

(3005322) IgE [Units/volume] in Serum or Plasma

1038

7774

1.21

8.02

1.4

1.3

297.96

273.13

u/ml

0.25

959

7182

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

292

1841

1.44

7.94

1.3

1.2

4.48

3.88

u/ml

0.33

131

863

(3002621) Streptococcal DNAse B [Units/volume] in Serum

142

2.67

7.90

1.0

526.75

191.71

u/ml

0.51

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

669

1.73

7.86

1.3

1.2

—

(3024932) HLA-DR beta [Type]

404

1.95

7.80

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

211

1252

1.53

7.78

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

121

626

1.75

7.71

2.2

2.6

0.62

0.61

mmol/l

0.31

121

626

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

294

1873

1.42

7.58

1.3

1.2

2.85

3.65

u/ml

0.61

112

685

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

543

3806

1.29

7.53

1.3

5.97

5.95

u/ml

0.00

592

(3008757) Leukocyte morphology finding [Identifier] in Blood

311

2004

1.41

7.52

3.4

4.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

323

2.04

7.50

1.3

33.81

276.64

u/l

1.01

230

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

6.77

7.50

4.7

4.5

—

(3024471) HLA-A [Type]

417

1.91

7.45

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

154

2.52

7.25

1.3

1.7

1.00

1.08

mmol/l

0.08

(3008295) Osmolality of Serum or Plasma

307

1989

1.40

7.21

1.4

1.3

277.86

276.27

mosm/kgh2o

0.52

226

1493

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

568

4030

1.28

7.18

1.3

1.2

62.97

39.67

u/ml

0.86

195

(3051387) C reactive protein [Mass/volume] in Capillary blood

525

3693

1.29

7.11

4.6

3.6

27.54

30.09

mg/l

0.98

386

2658

(3049717) Cytology report of Urine Cyto stain

1174

8999

1.19

7.09

2.7

2.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

539

3811

1.28

7.02

1.3

1.2

7.55

5.50

u/ml

0.23

389

(3015171) Extractable nuclear Ab [Units/volume] in Serum

697

5085

1.24

6.97

1.2

0.54

0.94

u/ml

0.75

441

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

868

6486

1.22

6.91

1.1

1.09

9.53

u/ml

0.91

(1761482) Bacteria [#/volume] in Urine by Culture

701

5123

1.24

6.90

5.3

4.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

257

1629

1.43

6.86

1.6

21.19

27.22

u/ml

1.02

348

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

243

1527

1.44

6.80

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

259

3264

0.71

6.75

1.7

1.6

—

(3000494) Fungus identified in Specimen by Culture

2410

19534

1.13

6.75

1.5

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

102

525

1.76

6.68

1.3

1.4

18.74

22.44

0.77

434

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

100

513

1.76

6.63

1.5

1.9

173.95

185.18

0.56

480

(3043410) Blood group antigens tested for on Red Blood Cells

508

1.76

6.56

1.8

2.0

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

120

651

1.67

6.52

1.4

23.18

19.90

0.65

590

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9141

78970

1.08

6.51

5.4

6.1

3.34

3.79

ug/l

0.68

8139

71024

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2970

24412

1.11

6.51

1.3

47.94

38.91

iu/ml

1.56

897

7391

(3045424) Erythrocytes [Presence] in Urine

1105

8492

1.18

6.50

2.4

2.2

0.31

0.12

estimate

0.34

242

2283

(44816559) Phosphatidylethanol [Mass/volume] in Blood

731

5404

1.23

6.49

1.5

1.7

0.34

0.32

mg/l

0.48

356

2613

(3042010) Triglyceride [Moles/volume] in Pleural fluid

348

1.92

6.47

1.3

1.15

1.12

mmol/l

0.01

227

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

474

3334

1.29

6.46

1.2

5.90

5.34

u/ml

0.05

233

(3001893) Eosinophils/Leukocytes in Pleural fluid

130

724

1.62

6.39

1.4

2.25

2.82

0.37

103

608

(3029634) Reagin Ab [Titer] in Serum by VDRL

248

1584

1.42

6.38

2.0

2.2

10.83

3.02

titre

—

(40757373) Influenza virus identified in Isolate

370

1.88

6.32

1.5

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

158

925

1.54

6.29

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

303

1.97

6.20

1.2

1.1

0.72

0.67

umol/24h

0.27

140

(3034274) Bile acid [Moles/volume] in Serum --fasting

113

612

1.67

6.20

1.2

1.4

11.67

15.27

umol/l

0.48

431

(3000475) Leukocytes [#/volume] in Synovial fluid

648

4756

1.24

6.18

1.5

1.6

18699.61

15476.06

e6/l

0.85

459

3366

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

248

1599

1.40

6.07

2.3

2.1

2.09

1.73

u/field

0.36

140

863

(3042111) Morphology [Interpretation] in Bone marrow Narrative

487

3468

1.27

6.05

1.5

1.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.31

6.03

30.0

11.2

108.36

106.57

g/l

0.22

(4146454) Self-monitoring of blood glucose

327

2209

1.34

6.00

3.1

2.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

397

1.82

5.97

1.3

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

287

1905

1.36

5.91

1.3

11.65

14.25

u/l

0.80

248

1765

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

188

2.21

5.87

1.2

0.79

0.33

u/ml

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

362

1.85

5.79

1.4

1.5

13.37

10.87

0.34

188

(3002619) Bacteria identified in Specimen by Culture

441

1.76

5.77

1.4

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

157

937

1.52

5.77

2.2

2.0

2.36

2.54

u/field

0.11

113

634

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

163

2162

0.68

5.73

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2758

22736

1.11

5.69

1.3

14.97

14.23

u/ml

0.17

874

8110

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1140

0.56

5.68

1.4

128.77

171.54

pmol/l

2.61

1140

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

218

1394

1.41

5.63

1.1

—

16.78

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

367

1.82

5.56

1.3

1.17

mmol/l

0.11

367

(3000093) Morphology [Interpretation] in Blood Narrative

292

1967

1.34

5.50

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

297

2010

1.34

5.43

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

254

1678

1.37

5.43

1.1

1.2

57.81

39.98

u/ml

0.50

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

109

607

1.62

5.43

1.5

1.6

3.74

9.80

nmol/l

0.89

528

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

219

2.06

5.40

5.1

5.8

47.04

49.64

ug/min

0.13

188

(3020191) Ethanol [Moles/volume] in Serum or Plasma

196

1240

1.43

5.39

1.4

1.07

1.20

promille

0.60

156

978

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

173

1072

1.46

5.32

3.7

3.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

466

1.71

5.31

1.2

18.22

13.50

pmol/l

0.56

177

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

275

1850

1.35

5.25

1.2

192.49

206.84

miu/ml

0.13

550

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

297

2030

1.32

5.10

1.1

1.66

1.56

g/l

3.25

266

1835

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

116

668

1.57

5.06

1.1

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

453

1.70

5.04

1.2

1.32

1.51

mmol/l

0.73

287

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

298

2046

1.32

4.97

1.2

20.20

6.52

u/ml

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

211

1376

1.39

4.93

1.4

1.3

118.95

532.19

titre

3.23

137

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

102

574

1.61

4.91

1.2

1.1

209.52

211.75

iu/ml

0.02

102

567

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

380

2703

1.27

4.86

1.2

34.95

48.50

u/ml

0.89

248

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

184

1176

1.41

4.84

1.2

91.63

104.47

pmol/l

2.80

184

1176

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

371

1.75

4.83

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

217

1428

1.37

4.81

1.1

1.51

2.15

iu/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

302

2092

1.31

4.75

3.4

3.6

—

(3013637) Mi-2 Ab [Presence] in Serum

476

1.65

4.70

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

476

1.65

4.70

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

476

1.65

4.70

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

476

1.65

4.70

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

396

1.71

4.63

1.1

1.3

0.33

0.31

g/l

1.69

322

(3026389) Candida sp identified in Specimen by Organism specific culture

301

2095

1.30

4.59

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

165

1046

1.43

4.56

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

320

2248

1.29

4.55

1.5

67.61

61.73

2.12

221

1405

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

486

5331

0.82

4.52

3.0

4.0

71.94

88.22

u/ml

0.56

464

5117

(4195642) Thrombophilia screening test

247

1676

1.33

4.52

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

127

767

1.50

4.51

3.5

3.8

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

267

1.86

4.50

1.2

1.4

79.14

71.36

1.39

222

(4281824) Cell count and differential, peritoneal fluid

111

1506

0.66

4.49

1.3

1.2

—

(4211845) Urine protein measurement

136

836

1.47

4.44

3.5

3.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

203

1341

1.37

4.43

1.4

1.3

77.86

63.47

titre

0.35

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

143

889

1.45

4.41

1.1

—

0.60

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

111

2.36

4.38

1.1

1.2

12464.60

2629.88

ng/l

1.09

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1735

14158

1.11

4.35

1.8

1.66

1.58

2.76

1424

11960

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

377

1.70

4.33

1.1

1.3

115.02

111.68

0.44

330

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

247

1689

1.32

4.31

1.2

1.1

112.81

114.83

0.41

219

1516

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

213

2563

0.75

4.29

1.3

1.2

1.40

1.49

g/l

5.69

213

2563

(3010144) Erythrocytes [#/volume] in Synovial fluid

260

1793

1.31

4.27

1.4

237817.16

150946.85

e6/l

0.80

171

1191

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

332

1.74

4.24

1.2

1.1

83.30

82.36

0.08

179

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

404

2963

1.23

4.03

1.1

2.10

3.38

1.82

239

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

331

1.72

4.01

1.2

74.17

82.16

0.88

183

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

340

1.70

3.93

1.2

98.50

99.07

0.03

315

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

388

1.65

3.93

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

161

1048

1.39

3.90

1.0

1.1

299.39

286.95

mg/l

1.22

146

946

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

171

1125

1.37

3.88

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

488

1.57

3.86

1.1

1.70

10.19

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

151

974

1.40

3.86

2.6

1.9

—

(3022145) Colonoscopy Study observation

2258

18789

1.09

3.84

1.3

1.4

—

(4268621) Lupus anticoagulant assay

190

1277

1.35

3.78

2.3

—

(3020491) Glucose [Moles/volume] in Blood

174

1154

1.36

3.77

2.3

2.0

7.83

7.28

mmol/l

1.30

119

784

(3008116) Ketones [Moles/volume] in Urine by Test strip

400

1.63

3.75

1.4

0.23

0.30

mmol/l

0.31

(40768795) Lymph node Pathology biopsy report

135

1703

0.71

3.75

1.3

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

219

1505

1.32

3.75

1.4

6.79

7.05

g/l

0.51

173

1062

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

296

2116

1.27

3.74

1.7

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

688

1.47

3.74

1.3

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

688

1.47

3.74

1.3

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

113

696

1.47

3.72

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4939

46742

0.94

3.67

3.2

3.5

0.80

0.81

ug/l

0.07

3558

32809

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

158

1037

1.38

3.67

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

250

1755

1.29

3.66

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

158

1038

1.38

3.65

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

491

0.48

3.65

12.3

14.2

884.08

799.66

nmol/l

0.47

465

(3024139) IgG subclass 3 [Mass/volume] in Serum

218

1504

1.31

3.64

1.4

0.45

0.44

g/l

0.06

172

1066

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

177

1185

1.35

3.63

2.3

25.76

27.13

iu/ml

0.08

181

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

234

1.81

3.62

1.2

71.68

79.65

0.60

(3028192) IgG subclass 2 [Mass/volume] in Serum

218

1505

1.31

3.62

1.4

2.89

2.94

g/l

0.18

173

1064

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

124

783

1.43

3.60

1.6

1.8

668.49

1070.53

u/l

0.21

244

(3036670) Protein [Mass/volume] in Synovial fluid

101

613

1.49

3.59

1.2

1.3

40.65

40.24

g/l

0.10

308

(40768804) Tissue Pathology biopsy report

6609

61945

0.94

3.53

2.3

—

(3032057) Clostridioides difficile [Presence] in Stool

414

1.59

3.52

2.3

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

112

697

1.45

3.52

1.4

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

104

638

1.47

3.52

1.1

1.11

1.07

ratio

1.31

519

(3006969) Lambda light chains [Mass/volume] in Urine

2.66

3.51

1.0

1.1

0.04

0.09

g/l

—

(3036603) Volume of Urine

188

1278

1.33

3.50

1.5

1.6

1837.75

1882.65

0.35

181

1232

(3026692) Albumin [Mass/volume] in Peritoneal fluid

537

1.51

3.48

1.4

16.34

13.37

g/l

2.36

400

(4062490) Immunoglobulin typing, IgG

213

1478

1.30

3.43

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

133

859

1.40

3.42

1.5

9.05

6.11

u/l

1.04

117

717

(3002331) Protein [Mass/volume] in Peritoneal fluid

483

1.53

3.38

1.5

1.4

29.21

41.12

g/l

0.46

373

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

194

1334

1.31

3.35

1.2

1.1

93.09

96.02

0.93

185

1231

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

149

985

1.37

3.35

1.5

1.4

16.72

14.38

umol/l

2.19

136

917

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

234

1.77

3.34

1.2

62.22

71.65

0.86

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

247

1755

1.27

3.33

1.4

14.48

13.36

u/l

1.77

239

1686

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

246

2797

0.79

3.31

1.4

1.3

0.79

0.89

g/l

7.51

240

2782

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

206

1433

1.30

3.28

1.2

91.11

77.23

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

457

3471

1.19

3.27

1.7

1.8

48.46

5.74

iu/l

0.90

163

1204

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

352

1.62

3.26

1.1

1.60

2.00

u/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

110

2.13

3.19

3.6

5.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

229

1623

1.28

3.17

1.3

1.2

56.66

50.81

u/ml

0.10

100

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

601

1.46

3.16

2.2

1.7

89906.56

26814.37

u/ml

0.34

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

232

1.75

3.14

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

239

1.74

3.13

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

592

4618

1.16

3.09

1.7

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

393

1.56

3.08

2.5

7.85

7.56

mmol/l

0.30

249

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

554

1.47

3.05

1.1

1818.84

1566.26

miu/ml

1.28

554

(3035082) Kappa light chains [Mass/volume] in Urine

2.46

3.04

1.0

1.1

0.05

0.14

g/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

554

4306

1.16

3.04

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

349

2607

1.21

3.02

1.2

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

146

1.92

2.89

1.4

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

176

1223

1.30

2.88

1.2

55.46

48.52

u/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

109

2.07

2.87

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.16

2.81

1.5

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

212

1518

1.26

2.75

1.3

1.2

—

37.40

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

362

1.55

2.73

1.2

1.1

15.76

22.66

iu/ml

—

(3020961) Endomysium IgA Ab [Titer] in Serum

677

5389

1.14

2.70

1.1

230.63

195.41

titre

—

137

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

237

1.68

2.68

1.2

121.95

501.74

ng/l

0.56

157

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

119

792

1.36

2.65

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

258

1900

1.23

2.63

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

212

1529

1.25

2.61

1.1

3.66

3.27

—

153

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

167

1924

0.78

2.60

3.2

3.6

26.24

41.04

u/ml

2.52

154

1867

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

332

3555

0.84

2.56

2.4

1.7

5.75

5.04

mg/l

0.37

272

2688

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

347

1.54

2.54

1.2

0.70

61.44

mg/l

1.51

269

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.53

2.52

5.6

4.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

383

2941

1.18

2.51

1.7

1.9

21.43

25.18

ug/l

1.21

372

2874

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

377

1.51

2.51

2.1

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

379

1.50

2.46

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

356

2723

1.18

2.45

1.1

1.2

0.30

0.90

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

128

875

1.32

2.42

1.2

—

(40768793) Breast Pathology biopsy report

240

2630

0.82

2.40

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

238

1.63

2.40

1.7

46.49

55.14

pmol/l

0.39

194

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.07

2.35

2.9

1.3

22.68

23.78

mmol/l

0.26

(3037692) Legionella sp identified in Specimen by Organism specific culture

654

1.37

2.35

1.3

1.4

—

(3022229) Phosphate [Moles/volume] in Urine

2.43

2.34

1.1

8.13

16.53

mmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

549

1.40

2.31

1.7

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.26

2.30

1.1

1.0

139.56

172.62

pmol/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

186

1.70

2.28

1.8

2.4

0.64

0.68

ug/l

0.33

186

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

125

862

1.31

2.25

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.76

2.25

1.1

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

187

1.69

2.24

3.7

3.1

1.69

1.18

mg/l

1.10

147

(3019420) Tryptase [Mass/volume] in Serum or Plasma

660

1.35

2.24

1.3

1.6

11.90

10.87

ug/l

0.09

608

(4035726) Immunohistochemistry procedure

1574

15229

0.93

2.23

1.4

—

(3047189) Immunofixation for 24 hour Urine

143

1008

1.28

2.19

1.5

1.7

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

152

1080

1.27

2.19

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

256

1925

1.20

2.18

1.2

1.3

—

(21494434) Karyotype in Bone marrow

243

1819

1.21

2.17

1.1

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

368

1.47

2.17

1.3

1.1

427.77

262.97

pmol/l

0.75

265

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

217

1.62

2.16

2.9

3.0

0.38

0.41

u/field

0.07

217

(3002079) Sodium [Moles/time] in 24 hour Urine

659

1.34

2.11

1.2

146.86

171.86

mmol/24h

1.96

659

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

140

991

1.28

2.09

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

109

747

1.32

2.08

1.3

163.92

252.89

ug/l

0.37

399

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

372

1.46

2.07

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

148

1057

1.26

2.06

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

5.01

2.04

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

126

884

1.29

2.03

3.5

1.28

1.24

0.10

126

884

(3018333) Ribosomal P Ab [Presence] in Serum

137

972

1.27

2.02

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

140

1.74

1.95

1.1

1.83

1.76

umol/24h

0.14

140

(3026470) Cobalt [Mass/volume] in Blood

118

1359

0.78

1.93

2.2

2.1

4.99

3.75

ug/l

0.47

112

1254

(3028707) Methadone [Presence] in Urine by Screen method

106

734

1.30

1.90

2.4

2.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.90

1.2

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

547

1.35

1.90

4.6

6.4

66.41

71.26

0.70

429

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

426

1.40

1.87

1.4

17.62

16.12

pmol/l

0.33

345

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

518

1.36

1.86

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1067

0.76

1.85

4.2

5.8

44.42

87.52

u/ml

1.44

344

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

117

1337

0.79

1.82

1.0

41.61

42.22

ng/l

0.06

921

(1761868) Lipid panel - Serum or Plasma

5031

46817

0.96

1.81

4.6

3.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

373

2945

1.14

1.80

1.1

18.63

10.99

eliau/ml

0.33

232

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

294

1.47

1.80

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

117

1334

0.79

1.79

1.0

714.64

714.53

ng/l

0.00

902

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

126

901

1.26

1.79

1.6

2.5

209.28

244.35

e6/l

0.99

110

798

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

603

0.69

1.78

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1030

1.25

1.78

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

469

1.37

1.77

1.3

31.59

33.40

0.16

305

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

137

0.39

1.77

1.8

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

122

0.37

1.76

2.0

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

547

1.34

1.76

1.2

0.06

0.65

g/l

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1032

1.24

1.76

1.2

—

(3024263) Appearance of Synovial fluid

129

928

1.26

1.75

1.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.38

1.74

1.2

1.3

1.17

1.94

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

100

697

1.30

1.74

1.0

1.1

9.17

9.98

iu/ml

0.11

165

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

139

1009

1.24

1.74

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.94

1.73

10.4

9.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

221

1686

1.18

1.69

1.1

21.14

21.11

au/ml

0.00

284

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

436

1.37

1.66

1.1

91.95

98.62

0.86

346

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7182

63286

1.04

1.65

4.7

4.9

23.13

22.13

5.99

3691

33590

(3047352) Trisomy 18 risk [Likelihood] in Fetus

118

0.38

1.63

2.0

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

177

1.58

1.62

1.3

1.4

—

576.45

—

(3050794) Legionella sp Ab [Presence] in Serum

149

1.64

1.61

1.1

—

(3044007) Cell count panel - Peritoneal fluid

627

1.30

1.60

2.4

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

340

1.41

1.60

1.1

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

119

1332

0.80

1.58

1.0

300.38

333.53

ng/l

0.82

932

(3046861) Legionella sp Ag [Presence] in Urine

122

1.70

1.58

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

796

0.75

1.58

5.2

7.1

15.63

168.11

ug/l

2.24

527

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

222

1.50

1.57

1.0

1233.33

810.53

titre

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

172

1.57

1.55

1.1

9.44

17.91

iu/ml

—

(3025577) Chromium [Mass/volume] in Blood

118

1317

0.81

1.54

2.2

2.87

2.16

ug/l

0.49

1090

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

140

1034

1.22

1.53

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

561

1.30

1.52

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

483

4827

0.90

1.51

1.8

42.59

44.74

nmol/l

1.32

463

4659

(3005011) Chlamydia sp Ab [Titer] in Serum

145

1.62

1.50

1.8

1.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

104

1.74

1.48

1.2

0.14

0.11

nmol/l

1.16

(3023511) Choriogonadotropin [Units/volume] in Urine

204

1.50

1.46

1.2

1.3

—

(3027874) Urate [Moles/volume] in Urine

1.94

1.46

1.1

1.48

1.78

mmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

256

1.45

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

138

1027

1.21

1.43

3.7

2.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

332

2653

1.13

1.41

1.8

3.75

4.83

mmol/24h

7.15

288

2281

(3042517) Benzodiazepines panel - Urine

2.11

1.41

1.8

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

243

1.45

1.40

1.2

1.3

74.75

107.42

ug/l

1.72

152

(4015189) Microbial culture of sputum

521

1.30

1.40

2.4

2.1

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

141

1.60

1.40

1.8

2.1

10.40

16.42

0.99

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

342

1.37

1.39

1.5

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1739

14919

1.06

1.39

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

657

1.26

1.39

2.0

2.3

52.44

54.66

umol/l

0.19

557

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.19

1.36

4.0

4.4

29.69

24.61

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.83

1.33

1.1

1.0

7.26

4.98

mmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1139

9671

1.07

1.30

1.2

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

255

1.42

1.30

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.71

1.29

1.1

0.03

u/ml

0.06

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

386

1.33

1.29

1.3

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.03

1.28

1.0

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

649

1.25

1.28

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

174

0.52

1.28

1.9

1.6

—

(40768443) Skin Pathology biopsy report

925

7807

1.07

1.27

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

404

1.32

1.25

1.6

2880.00

3654.05

titre

—

(3009015) Lactate [Moles/volume] in Synovial fluid

197

1.47

1.25

1.1

1.3

5.21

7.02

mmol/l

1.23

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1226

1.18

1.24

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2384

20682

1.04

1.23

6.3

5.3

33.26

32.84

1.10

1877

13134

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

119

889

1.21

1.23

1.6

2.3

483.38

522.68

e6/l

0.37

739

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.67

1.22

1.2

—

(3008898) HLA-B27 [Presence]

300

3030

0.89

1.20

1.1

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

431

1.30

1.19

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

101

745

1.22

1.19

2.5

1.9

2215.15

4276.13

e6/l

0.46

498

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

230

1.41

1.17

3.6

3.0

40.64

40.47

umol/l

0.01

188

(3029396) Erythrocyte agglutination [Presence] in Blood

1.87

1.14

1.9

1.5

—

(3002719) Hemoglobin [Mass/volume] in Urine

2.51

1.14

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

172

1.47

1.12

1.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

128

1.55

1.12

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

112

1208

0.84

1.12

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

637

1.23

1.11

2.2

1.8

14981.61

15539.21

e6/l

0.03

337

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.65

1.10

1.1

—

(3011412) CD3 cells [#/volume] in Blood

177

1384

1.15

1.10

1.9

2.2

1008.13

1080.38

e6/l

0.67

159

1255

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

203

1603

1.14

1.10

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

123

934

1.19

1.10

1.1

6.98

8.53

nmol/l

0.15

196

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

176

0.56

1.09

1.3

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

234

1.39

1.08

1.1

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

438

1.28

1.08

1.5

1.4

83.39

318.42

nmol/24h

1.55

438

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

296

1.34

1.08

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

519

1.25

1.07

1.1

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.75

1.04

1.1

211.63

522.74

u/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.26

1.01

1.2

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

629

1.22

1.01

1.3

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

253

1.36

1.01

3.6

3.3

6.88

7.60

mg/l

0.38

203

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

1437

0.86

1.01

1.4

1.5

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

890

0.82

1.01

6.6

3.7

13.59

13.35

0.84

878

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.62

0.99

1.2

1.4

1.00

1.04

u/field

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.85

0.98

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

863

1.18

0.97

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

191

0.61

0.96

1.9

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.80

0.96

1.0

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

1.80

0.96

1.1

1.0

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

179

1.41

0.95

2.2

65.95

60.19

0.43

118

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

383

1.27

0.94

1.6

9.57

9.68

ug/l

0.07

383

(3020717) Zinc [Moles/volume] in Serum or Plasma

668

1.20

0.94

1.4

16.78

22.17

umol/l

1.41

613

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

127

1.49

0.94

1.1

10.57

12.13

u/l

0.15

127

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

172

1.42

0.93

1.8

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.77

0.92

1.2

1.1

—

(4034850) Laboratory test

588

4957

1.07

0.91

18.4

12.0

—

(3000285) Sodium [Moles/volume] in Blood

417

1.26

0.91

1.5

1.3

137.94

138.38

mmol/l

0.49

345

(3002256) Pathology report gross observation

2423

22537

0.97

0.89

1.4

—

(3028714) Urate [Moles/time] in 24 hour Urine

2.08

0.89

1.0

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.65

0.87

1.4

1.7

0.80

0.19

u/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

300

1.29

0.87

1.1

1.0

1.09

0.21

u/ml

1.01

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

175

1.39

0.86

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

175

1.39

0.86

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

175

1.39

0.86

1.0

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

122

1270

0.87

0.85

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

277

1.30

0.85

1.3

17533.33

9436.87

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

197

1588

1.12

0.84

1.6

1.8

4.94

4.32

mg/l

0.96

185

1513

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

124

0.58

0.83

1.1

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

116

1.48

0.83

1.1

—

5.75

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

1.87

0.81

1.3

1.0

4.60

3.04

mmol/l

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.80

0.78

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

118

1.45

0.77

1.2

1.1

6.34

mmol/l

0.00

118

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

627

0.82

0.77

1.1

1.15

1.18

u/l

0.14

279

(44786800) Granulocytes/Leukocytes in Body fluid

298

1.27

0.77

1.4

1.3

15.56

24.52

1.44

230

(3009214) Lutropin [Units/volume] in Serum or Plasma

339

2823

1.08

0.77

1.3

1.4

11.94

9.49

u/l

1.60

252

2240

(3006245) CD3-CD19+ cells/cells in Blood

429

1.22

0.75

1.6

1.9

11.02

11.25

0.04

388

(3025130) Human papilloma virus identified in Specimen

820

0.85

0.75

1.5

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.05

0.73

1.2

321.60

282.90

u/ml

—

(1175426) CD3 cells/Lymphocytes in Blood

135

1075

1.13

0.73

1.9

72.88

70.09

1.27

129

1018

(3012494) Peanut IgE Ab [Units/volume] in Serum

197

1.33

0.73

1.1

1.0

1.35

1.04

u/ml

0.11

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

197

1.33

0.73

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

197

1605

1.11

0.72

3.5

3.0

124.15

43.55

mg/l

1.61

148

1179

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.59

0.72

1.0

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

253

1.28

0.72

1.2

1.1

15.22

19.59

u/l

1.31

163

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

116

917

1.14

0.71

1.6

1.3

1.89

1.42

u/ml

0.27

558

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

566

1.18

0.69

2.8

3.0

29.23

28.84

umol/l

0.10

426

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

163

1636

0.90

0.69

1.3

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.66

0.68

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

394

1.21

0.67

1.4

1.3

—

(3001729) Color of Synovial fluid

153

1.36

0.67

1.4

1.6

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

130

1.39

0.66

1.5

1.7

1.09

0.90

0.11

102

(3021387) Prolactin [Units/volume] in Serum or Plasma

280

2333

1.08

0.66

1.7

1.9

299.58

282.62

mu/l

0.37

253

2169

(3016879) Cocaine [Presence] in Urine

182

1488

1.10

0.65

1.9

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

363

1.22

0.65

1.1

1.0

2.84

1.19

u/ml

0.31

(3020393) Adenovirus Ag [Presence] in Stool

162

1.34

0.64

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

806

0.86

0.64

1.3

1.5

0.17

0.18

nmol/l

0.10

571

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

494

4715

0.94

0.63

1.5

1.6

—

(4198724) Urine methamphetamine measurement

259

1.25

0.62

1.5

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

930

8732

0.96

0.62

1.3

43.07

57.32

au/ml

1.47

594

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.64

0.62

1.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

548

1.17

0.62

1.4

74.65

59.01

4.51

465

(1617658) Protocol used for examination of sentinel lymph nodes

803

0.86

0.61

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1024

9589

0.96

0.61

2.4

2.5

20.43

23.12

au/ml

0.40

772

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

633

1.15

0.61

1.1

829.14

458.02

ng/l

0.43

195

(40761539) Cells [Type] in Urine sediment by Light microscopy

474

1.18

0.61

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

401

3845

0.94

0.60

1.8

1.9

194.30

197.92

pmol/l

0.33

377

3591

(3001964) Herpes simplex virus Ag [Presence] in Specimen

416

1.19

0.60

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

212

1.28

0.60

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

431

0.82

0.60

1.1

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.59

0.0

6.2

—

0.33

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.03

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

178

0.71

0.58

8.2

5.4

—

(3033099) Centromere Ab [Titer] in Serum

352

1.20

0.58

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

330

0.79

0.58

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.47

0.58

1.0

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.69

0.57

1.2

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.69

0.57

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.56

0.56

1.3

1.6

333.26

509.03

nmol/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.47

0.56

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

210

1744

1.09

0.56

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

109

875

1.12

0.56

1.2

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

345

1.20

0.56

1.3

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

258

0.77

0.56

1.7

1.5

0.78

1.09

u/ml

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

199

1.27

0.55

1.9

1.6

54.93

46.93

umol/l

0.54

199

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

805

6977

1.04

0.55

1.1

1.2

116.80

122.44

u/ml

0.15

286

2332

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

257

0.77

0.54

1.0

1.5

2.29

2.23

ug/l

0.05

144

(3020874) Milk IgE Ab [Units/volume] in Serum

388

1.19

0.54

1.1

1.0

1.73

0.84

u/ml

0.31

125

(3000060) B lymphocytes [#/volume] in Blood

265

1.23

0.53

1.5

1.8

1.10

2.46

e9/l

0.41

127

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.45

0.53

1.0

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.45

0.53

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.45

0.53

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

105

1.37

0.52

1.1

88.00

106.06

titre

0.51

105

(3000764) Benzodiazepines [Presence] in Urine

191

1587

1.09

0.52

1.9

1.7

—

(3034426) Prothrombin time (PT)

390

1.18

0.52

1.3

1.2

27.10

28.47

1.35

390

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

226

1.24

0.50

1.3

1.6

—

(3027008) Opiates [Presence] in Urine

192

1599

1.08

0.50

1.9

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

235

1.23

0.49

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

202

0.76

0.49

1.2

1.3

—

79.26

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

517

0.85

0.49

1.1

—

(3019174) dRVVT (LA screen)

1.37

0.48

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

335

1.18

0.48

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

107

1.35

0.48

1.7

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

311

0.81

0.48

2.1

1.9

7.72

8.49

mg/l

0.34

259

(4212803) Bone marrow aspirate examination

201

0.76

0.47

1.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

220

1.23

0.47

1.3

1.5

2.63

2.61

mmol/l

0.01

193

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.40

0.47

1.5

1.4

63.75

137.42

ug/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.44

0.46

1.5

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.43

0.46

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

159

0.74

0.46

2.3

0.42

11.41

ug/l

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

532

0.86

0.45

1.5

1.6

2.13

1.99

umol/l

0.48

491

(40762814) Titanium [Mass/volume] in Blood

367

0.84

0.45

2.5

2.4

2.79

3.63

ug/l

1.85

128

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

788

1.11

0.45

1.1

—

(3028300) Cannabinoids [Presence] in Urine

191

1603

1.08

0.44

1.9

1.7

—

(3020650) Glucose [Presence] in Urine

482

0.86

0.43

1.5

1.7

0.07

0.05

estimate

0.07

482

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

465

4382

0.96

0.43

2.7

3.3

2479.26

908.16

u/ml

0.48

415

3976

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

197

0.78

0.42

10.2

8.2

0.54

0.43

umol/l

0.25

177

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.42

1.2

1.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

489

0.87

0.41

1.0

1.1

0.63

3.81

u/ml

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

205

1732

1.07

0.40

1.6

1.5

19.02

27.89

4.45

138

1076

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

146

1218

1.08

0.40

2.0

1.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

401

0.85

0.40

1.8

2.8

146.36

134.66

nmol/l

0.30

351

(40758358) Immune stain study

1.34

0.40

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

143

1.26

0.40

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

145

0.75

0.40

1.3

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

253

2154

1.06

0.40

3.3

3.6

8.61

12.78

nmol/l

0.53

246

2103

(3045177) Copper [Moles/volume] in Urine

0.00

0.39

0.0

1.1

—

0.37

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.11

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.39

0.0

1.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.41

0.38

1.0

—

(3047185) IgG [Mass/volume] in Urine

1.37

0.37

1.0

1.1

—

43.05

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

161

1.23

0.37

2.8

2.7

—

(3027944) Amphetamines [Presence] in Urine

185

1565

1.07

0.37

1.9

1.7

—

(40765096) Chromosome analysis panel by Banding

597

0.89

0.36

1.1

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

348

0.86

0.36

3.3

2.7

764.71

1408.96

u/l

0.61

309

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

162

0.78

0.36

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

386

0.86

0.35

1.4

1.9

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

145

1219

1.07

0.35

1.2

2.29

2.26

mmol/l

0.12

127

1133

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

330

1.15

0.35

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.39

0.35

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.35

1.0

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

221

1.18

0.34

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

161

0.78

0.34

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

585

0.89

0.34

1.2

6.11

6.22

mmol/l

0.42

546

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

279

2396

1.05

0.34

2.4

2.6

1591.41

1069.22

u/ml

0.22

269

2366

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.37

0.33

1.0

1.1

309.80

250.75

nmol/l

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

668

0.90

0.33

1.2

67.88

58.23

—

(3034092) Cytoplasmic Ig cells/cells in Blood

165

1.20

0.31

17.0

10.2

0.42

0.23

0.71

165

(44806420) Estimation of glomerular filtration rate

126

1217

0.93

0.31

2.5

2.7

—

(1002224) Polysomnography panel

528

4917

0.97

0.31

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

138

0.78

0.30

1.1

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

429

1.11

0.30

1.9

2.9

2.22

1.76

ratio

0.85

391

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

133

1277

0.94

0.28

1.8

2.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

109

1.24

0.28

1.1

1.0

0.07

0.80

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

790

7298

0.98

0.28

2.8

3.4

1414.09

2175.64

u/ml

0.43

654

6335

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

463

4310

0.97

0.28

1.5

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

445

3886

1.03

0.27

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

185

0.83

0.27

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

161

1533

0.95

0.27

1.8

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.22

0.27

1.4

1.6

60.84

57.33

ug/l

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.22

0.27

7.3

6.3

6.25

8.51

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.31

0.26

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.20

0.26

3.6

3.1

57.13

40.57

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

102

861

1.07

0.25

1.5

2.1

16.22

15.41

nmol/l

0.57

793

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

539

1.09

0.25

1.0

1.1

13.74

22.31

u/ml

0.88

187

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

103

1.23

0.24

1.6

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

191

0.85

0.23

1.2

1.1

68.89

63.47

ug/l

0.44

191

(3007733) Chloride [Moles/volume] in Urine

1.33

0.23

1.2

1.1

99.60

84.07

mmol/l

—

(44813793) Dust mix specific IgE antibody measurement

796

1.07

0.22

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

421

1.09

0.22

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.22

0.22

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

335

1.10

0.22

1.2

1.3

146.34

70.43

mu/l

1.04

241

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

510

0.92

0.21

1.3

1.2

122.39

134.52

nmol/l

0.26

353

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

164

1.16

0.21

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

842

1.06

0.21

1.5

1.9

382.82

318.38

mu/l

0.80

643

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

105

1.20

0.21

1.7

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

453

0.92

0.21

2.1

2.4

41.87

642.90

ug/l

1.52

453

(3044009) aPTT.lupus sensitive (LA screen)

1.21

0.20

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.26

0.20

1.8

1.3

39.33

63.73

umol/24h

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

0.20

0.0

1.5

—

15.15

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

114

1.19

0.20

1.1

0.90

1.10

u/field

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

581

1.07

0.20

1.2

0.48

0.64

ratio

0.80

351

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

292

0.90

0.20

1.4

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

159

0.85

0.20

1.1

22.97

36.56

iu/ml

0.87

159

(3036071) Salmonella sp Ab [Titer] in Serum

346

1.09

0.20

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

120

0.83

0.19

1.5

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

158

1.14

0.18

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

755

0.94

0.18

4.7

5.8

36.10

376.68

u/ml

—

121

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

227

1.11

0.17

1.1

1.2

45.60

49.33

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

185

0.88

0.17

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

393

1.08

0.17

1.5

1.6

0.53

0.39

ug/l

1.49

264

(3045683) HLA typing for celiac disease panel - Blood or Tissue

539

0.94

0.16

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

353

0.92

0.16

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

108

0.84

0.16

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.78

0.15

1.5

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

430

1.07

0.15

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

144

1252

1.04

0.15

1.1

1.0

1.48

0.81

u/ml

0.54

520

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

126

1.15

0.15

1.4

0.75

0.93

ml/s/173m2

—

(3016018) Differential panel - Cerebral spinal fluid

179

1666

0.97

0.14

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.81

0.14

1.0

1.67

6.81

u/ml

—

(4133840) Spirometry

353

1.07

0.14

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

759

1.05

0.13

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.80

0.13

1.1

1.3

261.63

351.98

umol/24h

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.85

0.13

3.0

2.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.82

0.13

1.2

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

209

0.91

0.13

1.0

4.62

7.74

u/ml

0.68

112

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

187

1641

1.03

0.12

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

105

912

1.04

0.12

1.1

1.0

2.05

2.21

u/ml

0.06

393

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

452

1.06

0.12

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

461

1.06

0.12

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

403

0.94

0.12

1.1

1.3

12.07

13.03

mm/h

0.24

403

(3003888) Timothy IgE Ab [Units/volume] in Serum

147

1287

1.03

0.12

1.1

1.0

2.72

2.62

u/ml

0.04

609

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

844

1.04

0.11

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

256

2263

1.02

0.11

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

217

1.08

0.10

1.4

2.0

3.73

5.75

pmol/l

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

349

1.06

0.10

1.0

1.2

1.65

2.82

umol/l

5.29

295

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

621

0.96

0.10

1.4

1.5

27.08

28.79

umol/l

0.71

587

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2333

20923

1.01

0.10

3.5

4.3

9.17

28.49

ug/l

10.35

1943

17578

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

368

1.05

0.09

1.1

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

131

0.89

0.09

1.1

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

112

0.89

0.09

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.10

0.09

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

263

1.06

0.09

1.1

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

1.08

0.08

1.0

1.2

88.67

82.91

umol/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

158

0.91

0.08

2.1

3.5

37.00

160.63

ng/l

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

818

0.97

0.08

1.0

1.09

0.22

u/ml

0.47

299

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.78

0.08

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.11

0.08

1.3

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

163

1440

1.02

0.08

1.2

7.86

7.89

mmol/l

0.04

137

1197

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

362

3307

0.99

0.08

1.4

567.55

2085.57

e6/l

1.47

296

2647

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

851

1.03

0.08

1.1

41.04

46.95

mg/l

0.98

733

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

268

0.94

0.08

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.03

0.07

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

184

0.93

0.07

3.3

2.7

7.83

7.57

mmol/l

—

100

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

756

1.03

0.06

1.1

—

1.70

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

801

1.02

0.06

1.1

314.38

319.39

mg/l

0.09

714

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

109

0.91

0.05

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

143

1.07

0.05

2.4

1.9

13.73

18.39

umol/l

1.67

143

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

374

0.96

0.05

2.5

2.3

1.16

0.90

ug/l

0.41

355

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

182

0.94

0.05

2.4

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

110

975

1.02

0.04

1.1

1.0

4.33

2.49

u/ml

0.71

469

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

800

0.98

0.04

1.3

39.55

29.50

u/l

1.72

648

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

101

927

0.98

0.04

2.2

2.7

37.12

36.19

0.22

508

(3051101) Glucose [Moles/volume] in Cord blood

391

0.97

0.04

5.9

9.92

8.58

mmol/l

1.90

391

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

425

3806

1.01

0.04

1.3

669.85

580.59

mg/l

0.57

399

3639

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

190

0.95

0.04

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

454

0.97

0.04

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

100

1.08

0.04

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

227

2028

1.01

0.04

1.3

1.4

30.16

31.60

iu/l

0.23

181

1716

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

654

5873

1.00

0.03

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

374

3355

1.01

0.03

1.2

4.18

3.87

mmol/l

4.28

351

3172

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

252

0.97

0.02

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

155

1385

1.01

0.02

1.6

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

837

1.01

0.02

1.8

2.0

38.31

39.85

g/l

1.70

837

(3009466) Valproate [Moles/volume] in Serum or Plasma

248

2223

1.01

0.02

4.5

4.6

341.01

335.62

umol/l

0.24

212

1891

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

459

0.98

0.02

1.1

1.2

13.83

26.09

—

(44806071) Cardiolipin IgM antibody measurement

169

0.96

0.01

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

174

1579

0.99

0.01

1.2

1.1

2.33

1.10

u/ml

0.81

100

870

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

111

1.06

0.01

1.2

1.0

95.29

83.84

ug/l

—

(40768441) Liver Pathology biopsy report

129

1155

1.01

0.01

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

156

1399

1.01

0.01

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

105

0.94

0.01

1.1

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

132

0.96

0.01

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

154

1396

0.99

0.01

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

229

1.02

0.00

2.3

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.06

0.00

6.6

5.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

1005

1.01

0.00

1.8

2.4

0.69

0.59

e9/l

0.51

101

947

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

105

1.03

0.00

2.8

3.2

3.93

65.02

pmol/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

195

1.02

0.00

1.2

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

876

1.00

0.00

1.6

1.5

3.34

3.83

0.15

185

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

362

3264

1.00

0.00

1.3

1.4

14.99

29.78

e6/l

1.30

281

2452

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.05

0.00

1.2

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

124

1121

1.00

0.00

1.1

1.0

1.31

0.88

u/ml

0.48

565

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

1.00

0.00

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

126

1.00

0.00

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

142

1283

1.00

0.00

1.1

10.57

4.05

eliau/ml

0.84

426

(40765089) Chromosome analysis panel - Blood by G-banded

100

0.99

0.00

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

21.0

—

4.31

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.99

-0.00

1.3

1.4

—

(3013466) aPTT in Blood by Coagulation assay

0.87

-0.00

1.2

1.1

40.00

39.54

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

2.56

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.97

-0.00

1.0

1.3

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

41.80

—

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

32.75

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.92

-0.00

2.2

2.6

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

8.80

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.92

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: I9_NSTEMI – Myocardial infarction, without ST-elevation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Myocardial infarction, without ST-elevation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Myocardial infarction, without ST-elevation (I9_NSTEMI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints